{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T17:47:10Z","timestamp":1775756830969,"version":"3.50.1"},"reference-count":491,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.biopha.2021.111563","type":"journal-article","created":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T22:55:06Z","timestamp":1618700106000},"page":"111563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["On the therapeutic targets and pharmacological treatments for pain relief following spinal cord injury: A mechanistic review"],"prefix":"10.1016","volume":"139","author":[{"given":"Sajad","family":"Fakhri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Abbaszadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoumeh","family":"Jorjani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.111563_bib1","unstructured":"N.-H. White, N.-H. Black, Spinal Cord Injury Facts and Figures at a Glance, 2017."},{"key":"10.1016\/j.biopha.2021.111563_bib2","doi-asserted-by":"crossref","first-page":"e345","DOI":"10.1016\/j.wneu.2018.02.033","article-title":"Traumatic spinal injury: global epidemiology and worldwide volume","volume":"113","author":"Kumar","year":"2018","journal-title":"World Neurosurg."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ejp.905","article-title":"Neuropathic pain prevalence following spinal cord injury: a systematic review and meta\u2010analysis","volume":"21","author":"Burke","year":"2017","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.biopha.2021.111563_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jns.2017.11.018","article-title":"Neuropathic pain and SCI: identification and treatment strategies in the 21st century","volume":"384","author":"Hatch","year":"2018","journal-title":"J. Neurol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2021.111563_bib5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11916-010-0140-8","article-title":"Central pain syndromes","volume":"14","author":"Wasner","year":"2010","journal-title":"Curr. Pain Headache Rep."},{"key":"10.1016\/j.biopha.2021.111563_bib6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nbd.2012.12.012","article-title":"A toll-like receptor 9 antagonist reduces pain hypersensitivity and the inflammatory response in spinal cord injury","volume":"54","author":"David","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biopha.2021.111563_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2018.08.012","article-title":"Astaxanthin: a mechanistic review on its biological activities and health benefits","volume":"136","author":"Fakhri","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s13311-018-0633-4","article-title":"Neuropathic pain after spinal cord injury: challenges and research perspectives","volume":"15","author":"Shiao","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib9","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1471-4159.2005.03462.x","article-title":"Transcriptional profiling of spinal cord injury\u2010induced central neuropathic pain","volume":"95","author":"Nesic","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2021.111563_bib10","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.brainres.2014.05.003","article-title":"Chronic at-level thermal hyperalgesia following rat cervical contusion spinal cord injury is accompanied by neuronal and astrocyte activation and loss of the astrocyte glutamate transporter, GLT1, in superficial dorsal horn","volume":"1581","author":"Putatunda","year":"2014","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.biopha.2021.111563_bib11","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1177\/1545968312445637","article-title":"Herpes simplex virus vector\u2013mediated expression of interleukin-10 reduces below-level central neuropathic pain after spinal cord injury","volume":"26","author":"Lau","year":"2012","journal-title":"Neurorehabilit. Neural Repair"},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","article-title":"Cellular and molecular mechanisms of pain","volume":"139","author":"Basbaum","year":"2009","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11916-011-0186-2","article-title":"Neuronal hyperexcitability: a substrate for central neuropathic pain after spinal cord injury","volume":"15","author":"Gwak","year":"2011","journal-title":"Curr. Pain Headache Rep."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.biopha.2021.111563_bib15","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.apmr.2014.06.010","article-title":"Gabapentinoids are effective in decreasing neuropathic pain and other secondary outcomes after spinal cord injury: a meta-analysis","volume":"95","author":"Mehta","year":"2014","journal-title":"Arch. Phys. Med. Rehabil."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/sc.2013.146","article-title":"Anticonvulsant medication use for the management of pain following spinal cord injury: systematic review and effectiveness analysis","volume":"52","author":"Guy","year":"2014","journal-title":"Spinal Cord"},{"key":"10.1016\/j.biopha.2021.111563_bib17","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2147\/JPR.S45966","article-title":"Systematic review and comparison of pharmacologic therapies for neuropathic pain associated with spinal cord injury","volume":"6","author":"Snedecor","year":"2013","journal-title":"JPR"},{"key":"10.1016\/j.biopha.2021.111563_bib18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-pharmtox-010818-021524","article-title":"Neuropathic pain: mechanism-based therapeutics","volume":"60","author":"Bannister","year":"2020","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"12","key":"10.1016\/j.biopha.2021.111563_bib19","first-page":"605","article-title":"Pain in patients with spinal cord injury","volume":"60","author":"Nepomuceno","year":"1979","journal-title":"Arch. Phys. Med. Rehabil."},{"issue":"7","key":"10.1016\/j.biopha.2021.111563_bib20","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/sj.sc.3100411","article-title":"Chronic pain\/dysaesthesiae in spinal cord injury patients: results of a multicentre study","volume":"35","author":"St\u00f6rmer","year":"1997","journal-title":"Spinal Cord"},{"issue":"6","key":"10.1016\/j.biopha.2021.111563_bib21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/sc.2011.156","article-title":"International spinal cord injury pain classification: part I. Background and description","volume":"50","author":"Bryce","year":"2012","journal-title":"Spinal Cord"},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib22","article-title":"The international association for the study of pain definition of pain: as valid in 2018 as in 1979, but in need of regularly updated footnotes","volume":"3","author":"Treede","year":"2018","journal-title":"Pain Rep."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib23","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.brainresrev.2008.12.010","article-title":"Mechanisms of chronic central neuropathic pain after spinal cord injury","volume":"60","author":"Hulsebosch","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.biopha.2021.111563_bib24","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.pain.2012.12.007","article-title":"Pain in patients with spinal cord injury","volume":"154","author":"Finnerup","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2021.111563_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neulet.2016.02.005","article-title":"Neuropathic pain induced by spinal cord injury: role of endothelin ETA and ETB receptors","volume":"617","author":"Forner","year":"2016","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib26","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.apmr.2014.11.024","article-title":"Efficacy of venlafaxine XR for the treatment of pain in patients with spinal cord injury and major depression: a randomized, controlled trial","volume":"96","author":"Richards","year":"2015","journal-title":"Arch. Phys. Med. Rehabil."},{"issue":"7","key":"10.1016\/j.biopha.2021.111563_bib27","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1526-4637.2010.00865.x","article-title":"Chronic pain after spinal cord injury: results of a long-term study","volume":"11","author":"Modirian","year":"2010","journal-title":"Pain Med."},{"issue":"7","key":"10.1016\/j.biopha.2021.111563_bib28","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.jse.2011.03.021","article-title":"A cross-sectional study of demographic and morphologic features of rotator cuff disease in paraplegic patients","volume":"20","author":"Akbar","year":"2011","journal-title":"J. Shoulder Elb. Surg."},{"issue":"6","key":"10.1016\/j.biopha.2021.111563_bib29","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2165\/00023210-200822060-00002","article-title":"Pharmacological management of neuropathic pain following spinal cord injury","volume":"22","author":"Baastrup","year":"2008","journal-title":"CNS Drugs"},{"issue":"33","key":"10.1016\/j.biopha.2021.111563_bib30","doi-asserted-by":"crossref","first-page":"10989","DOI":"10.1523\/JNEUROSCI.5110-13.2014","article-title":"Spinal cord injury causes brain inflammation associated with cognitive and affective changes: role of cell cycle pathways","volume":"34","author":"Wu","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2021.111563_bib31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bbr.2017.01.025","article-title":"Effect of ZBD-2 on chronic pain, depressive-like behaviors, and recovery of motor function following spinal cord injury in mice","volume":"322","author":"Li","year":"2017","journal-title":"Behav. Brain Res."},{"issue":"12","key":"10.1016\/j.biopha.2021.111563_bib32","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.pmrj.2009.07.002","article-title":"Pain after spinal cord injury: a review of classification, treatment approaches, and treatment assessment","volume":"1","author":"Cardenas","year":"2009","journal-title":"PMR"},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1054\/jpai.2001.22788","article-title":"Conditions affecting the onset, severity, and progression of a spontaneous pain-like behavior after excitotoxic spinal cord injury","volume":"2","author":"Gorman","year":"2001","journal-title":"J. Pain"},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1124\/pr.117.014399","article-title":"Etiology and pharmacology of neuropathic pain","volume":"70","author":"Alles","year":"2018","journal-title":"Pharmacol. Rev."},{"issue":"23","key":"10.1016\/j.biopha.2021.111563_bib35","first-page":"3257","article-title":"Neuropathic pain following spinal cord injury: what we know about mechanisms, assessment and management","volume":"17","author":"D\u2019Angelo","year":"2013","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2021.111563_bib36","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1474-4422(12)70134-5","article-title":"The role of the immune system in the generation of neuropathic pain","volume":"11","author":"Calvo","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biopha.2021.111563_bib37","doi-asserted-by":"crossref","DOI":"10.1186\/s12990-015-0029-y","article-title":"Novel expression pattern of neuropeptide Y immunoreactivity in the peripheral nervous system in a rat model of neuropathic pain","volume":"11","author":"Magnussen","year":"2015","journal-title":"Mol. Pain"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib38","article-title":"Peripheral nerve injury is accompanied by chronic transcriptome-wide changes in the mouse prefrontal cortex","volume":"9","author":"Alvarado","year":"2013","journal-title":"Mol. Pain"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055259","article-title":"Peripheral nerve injury is associated with chronic, reversible changes in global DNA methylation in the mouse prefrontal cortex","volume":"8","author":"Tajerian","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib40","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/ALN.0000000000000403","article-title":"Brain neuroplastic changes accompany anxiety and memory deficits in a model of complex regional pain syndrome","volume":"121","author":"Tajerian","year":"2014","journal-title":"Anesthesiology"},{"issue":"12","key":"10.1016\/j.biopha.2021.111563_bib41","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.tig.2007.09.004","article-title":"Genetic architecture of human pain perception","volume":"23","author":"Diatchenko","year":"2007","journal-title":"Trends Genet."},{"issue":"11","key":"10.1016\/j.biopha.2021.111563_bib42","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm1490","article-title":"GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence","volume":"12","author":"Tegeder","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2021.111563_bib43","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3389\/fncel.2018.00158","article-title":"Epigenetic modifications associated to neuroinflammation and neuropathic pain after neural trauma","volume":"12","author":"Penas","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.biopha.2021.111563_bib44","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neuroscience.2017.02.041","article-title":"EZH2 regulates spinal neuroinflammation in rats with neuropathic pain","volume":"349","author":"Yadav","year":"2017","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib45","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1471-4159.2012.07786.x","article-title":"Molecular mechanism of Jmjd3\u2013mediated interleukin\u20106 gene regulation in endothelial cells underlying spinal cord injury","volume":"122","author":"Lee","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2021.111563_bib46","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neuroscience.2013.02.053","article-title":"Epigenetic regulation of BDNF expression in the primary sensory neurons after peripheral nerve injury: implications in the development of neuropathic pain","volume":"240","author":"Uchida","year":"2013","journal-title":"Neuroscience"},{"issue":"9","key":"10.1016\/j.biopha.2021.111563_bib47","first-page":"10901","article-title":"MiR-19a targets suppressor of cytokine signaling 1 to modulate the progression of neuropathic pain","volume":"8","author":"Wang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib48","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s12031-016-0748-1","article-title":"Inhibition of microRNA-221 alleviates neuropathic pain through targeting suppressor of cytokine signaling 1","volume":"59","author":"Xia","year":"2016","journal-title":"J. Mol. Neurosci."},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib49","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s11064-014-1500-2","article-title":"Suppression of microRNA-155 attenuates neuropathic pain by regulating SOCS1 signalling pathway","volume":"40","author":"Tan","year":"2015","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.biopha.2021.111563_bib50","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neulet.2016.12.047","article-title":"Overexpression of miR-206 ameliorates chronic constriction injury-induced neuropathic pain in rats via the MEK\/ERK pathway by targeting brain-derived neurotrophic factor","volume":"646","author":"Sun","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2021.111563_bib51","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bbi.2015.04.018","article-title":"MicroRNA-146a-5p attenuates neuropathic pain via suppressing TRAF6 signaling in the spinal cord","volume":"49","author":"Lu","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.biopha.2021.111563_bib52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0079-6123(06)61007-8","article-title":"Substance P in traumatic brain injury","volume":"161","author":"Donkin","year":"2007","journal-title":"Prog. Brain Res."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib53","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3390\/ijms19010120","article-title":"Overview of the microenvironment of vasculature in vascular tone regulation","volume":"19","author":"Loh","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib54","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2174\/1570159X15666170911121027","article-title":"5-HT1, 5-HT2, 5-HT3 and 5-HT7 receptors and their role in the modulation of pain response in the central nervous system","volume":"16","author":"Cortes-Altamirano","year":"2018","journal-title":"Curr. Neuropharmacol."},{"issue":"8","key":"10.1016\/j.biopha.2021.111563_bib55","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.3390\/ijms19082164","article-title":"General pathways of pain sensation and the major neurotransmitters involved in pain regulation","volume":"19","author":"Yam","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib56","doi-asserted-by":"crossref","first-page":"1007S","DOI":"10.1093\/jn\/130.4.1007S","article-title":"Glutamate as a neurotransmitter in the brain: review of physiology and pathology","volume":"130","author":"Meldrum","year":"2000","journal-title":"J. Nutr."},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib57","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1124\/mi.4.5.3","article-title":"The role of reactive oxygen species (ROS) in persistent pain","volume":"4","author":"Chung","year":"2004","journal-title":"Mol. Interv."},{"key":"10.1016\/j.biopha.2021.111563_bib58","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.pain.2004.06.008","article-title":"Reactive oxygen species (ROS) play an important role in a rat model of neuropathic pain","volume":"111","author":"Kim","year":"2004","journal-title":"Pain"},{"issue":"1\u20133","key":"10.1016\/j.biopha.2021.111563_bib59","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.pain.2009.09.030","article-title":"Peripheral and central sensitization in remote spinal cord regions contribute to central neuropathic pain after spinal cord injury","volume":"147","author":"Carlton","year":"2009","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib60","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1152\/physrev.00052.2017","article-title":"The role of voltage-gated sodium channels in pain signaling","volume":"99","author":"Bennett","year":"2019","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib61","first-page":"9","article-title":"Role of decreased sensory neuron membrane calcium currents in the genesis of neuropathic pain","volume":"48","author":"Hogan","year":"2007","journal-title":"Croat. Med. J."},{"key":"10.1016\/j.biopha.2021.111563_bib62","series-title":"NMDA Antagonists as Potential Analgesic Drugs","first-page":"83","article-title":"The NMDA receptor, pain and central sensitization","author":"Ma","year":"2002"},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib63","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.neuropharm.2010.12.030","article-title":"GABA and central neuropathic pain following spinal cord injury","volume":"60","author":"Gwak","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2021.111563_bib64","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fphys.2018.00095","article-title":"Neuropathic pain: delving into the oxidative origin and the possible implication of transient receptor potential channels","volume":"9","author":"Carrasco","year":"2018","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib65","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1152\/jn.00775.2010","article-title":"Adrenergic receptors modulate motoneuron excitability, sensory synaptic transmission and muscle spasms after chronic spinal cord injury","volume":"105","author":"Rank","year":"2011","journal-title":"J. Neurophysiol."},{"issue":"10","key":"10.1016\/j.biopha.2021.111563_bib66","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/sc.2016.28","article-title":"Evaluation of the effects of specific opioid receptor agonists in a rodent model of spinal cord injury","volume":"54","author":"Aceves","year":"2016","journal-title":"Spinal Cord"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib67","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jdi.12379","article-title":"Microglia in the spinal cord and neuropathic pain","volume":"7","author":"Tsuda","year":"2016","journal-title":"J. Diabetes Investig."},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib68","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/sc.2015.225","article-title":"Neuroplasticity of ascending and descending pathways after somatosensory system injury: reviewing knowledge to identify neuropathic pain therapeutic targets","volume":"54","author":"Boadas-Vaello","year":"2016","journal-title":"Spinal Cord"},{"key":"10.1016\/j.biopha.2021.111563_bib69","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fncel.2016.00098","article-title":"Inflammogenesis of secondary spinal cord injury","volume":"10","author":"Anwar","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.biopha.2021.111563_bib70","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00441-019-03039-1","article-title":"Spinal cord injury: pathophysiology, treatment strategies, associated challenges, and future implications","volume":"377","author":"Venkatesh","year":"2019","journal-title":"Cell Tissue Res."},{"issue":"11","key":"10.1016\/j.biopha.2021.111563_bib71","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.4103\/1673-5374.194710","article-title":"Anti-inflammatory properties of the glial scar","volume":"11","author":"Gesteira","year":"2016","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.biopha.2021.111563_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/845323","article-title":"Chondroitin sulfate proteoglycans in the nervous system: inhibitors to repair","volume":"2014","author":"Siebert","year":"2014","journal-title":"BioMed Res. Int."},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib73","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1007\/s12035-013-8620-6","article-title":"Phagocytosis of microglia in the central nervous system diseases","volume":"49","author":"Fu","year":"2014","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib74","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1471-4159.2008.05426.x","article-title":"Myelin\u2010induced microglial neurotoxicity can be controlled by microglial metabotropic glutamate receptors","volume":"106","author":"Pinteaux\u2010Jones","year":"2008","journal-title":"J. Neurochem."},{"issue":"10","key":"10.1016\/j.biopha.2021.111563_bib75","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1113\/JP272117","article-title":"Zn2+\u2010 induced Ca2+ release via ryanodine receptors triggers calcineurin\u2010dependent redistribution of cortical neuronal Kv2.1 K+ channels","volume":"594","author":"Schulien","year":"2016","journal-title":"J. Physiol."},{"key":"10.1016\/j.biopha.2021.111563_bib76","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0079-6123(06)61013-3","article-title":"Sodium channel expression and the molecular pathophysiology of pain after SCI","volume":"161","author":"Hains","year":"2007","journal-title":"Prog. Brain Res."},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib77","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s00221-006-0511-x","article-title":"Upregulation of persistent and ramp sodium current in dorsal horn neurons after spinal cord injury","volume":"174","author":"Lampert","year":"2006","journal-title":"Exp. Brain Res."},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib78","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s12031-012-9840-3","article-title":"Role of microglia and astrocyte in central pain syndrome following electrolytic lesion at the spinothalamic tract in rats","volume":"49","author":"Naseri","year":"2013","journal-title":"J. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/nbdi.2000.0360","article-title":"Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain","volume":"8","author":"Ji","year":"2001","journal-title":"Neurobiol. Dis."},{"issue":"9","key":"10.1016\/j.biopha.2021.111563_bib80","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","article-title":"EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision","volume":"17","author":"Attal","year":"2010","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib81","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/10790268.1997.11719468","article-title":"Management of pain in persons with spinal cord injury","volume":"20","author":"Ragnarsson","year":"1997","journal-title":"J. Spinal Cord Med."},{"issue":"6","key":"10.1016\/j.biopha.2021.111563_bib82","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2217\/pmt.15.47","article-title":"Spinal cord injury-induced pain: mechanisms and treatments","volume":"5","author":"Siddall","year":"2015","journal-title":"Pain Manag."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169623","article-title":"Anxiety and depression in patients with traumatic spinal cord injury: a nationwide population-based cohort study","volume":"12","author":"Lim","year":"2017","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.biopha.2021.111563_bib84","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/sc.2016.15","article-title":"Anxiety prevalence following spinal cord injury: a meta-analysis","volume":"54","author":"Le","year":"2016","journal-title":"Spinal Cord"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib85","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.apmr.2014.08.016","article-title":"Prevalence of depression after spinal cord injury: a meta-analysis","volume":"96","author":"Williams","year":"2015","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.biopha.2021.111563_bib86","series-title":"Essentials of Pain Medicine","first-page":"445","article-title":"Recommendations for pharmacologic therapy of neuropathic pain","author":"Haroutounian","year":"2018"},{"issue":"6","key":"10.1016\/j.biopha.2021.111563_bib87","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1742-7843.2005.pto_96696601.x","article-title":"Antidepressants in the treatment of neuropathic pain","volume":"96","author":"Sindrup","year":"2005","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"11","key":"10.1016\/j.biopha.2021.111563_bib88","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.3390\/ijms18112483","article-title":"Analgesic mechanisms of antidepressants for neuropathic pain","volume":"18","author":"Obata","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.111563_bib89","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fnint.2012.00087","article-title":"Biological implications of coeruleospinal inhibition of nociceptive processing in the spinal cord","volume":"6","author":"Tsuruoka","year":"2012","journal-title":"Front. Integr. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib90","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pharmthera.2007.09.003","article-title":"Modulation of pain transmission by G-protein-coupled receptors","volume":"117","author":"Pan","year":"2008","journal-title":"Pharmacol. Ther."},{"issue":"5\u20136","key":"10.1016\/j.biopha.2021.111563_bib91","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/FBP.0b013e328349aae4","article-title":"The complex role of serotonin and 5-HT receptors in chronic pain","volume":"22","author":"Bardin","year":"2011","journal-title":"Behav. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib92","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.pain.2006.02.033","article-title":"Depletion of endogenous spinal 5-HT attenuates the behavioural hypersensitivity to mechanical and cooling stimuli induced by spinal nerve ligation","volume":"123","author":"Rahman","year":"2006","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib93","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1113\/jphysiol.1988.sp017084","article-title":"Antinociceptive actions of descending dopaminergic tracts on cat and rat dorsal horn somatosensory neurones","volume":"399","author":"Fleetwood-Walker","year":"1988","journal-title":"J. Physiol."},{"issue":"19","key":"10.1016\/j.biopha.2021.111563_bib94","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJM199205073261904","article-title":"Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy","volume":"326","author":"Max","year":"1992","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.biopha.2021.111563_bib95","article-title":"Trazodone hydrochloride in the treatment of dysesthetic pain in traumatic myelopathy: a randomized, double-blind","author":"Davidoff","year":"1987","journal-title":"Place -Control Study"},{"issue":"8","key":"10.1016\/j.biopha.2021.111563_bib96","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.apmr.2015.12.023","article-title":"Systematic review of pharmacologic treatments of pain after spinal cord injury: an update","volume":"97","author":"Mehta","year":"2016","journal-title":"Arch. Phys. Med. Rehabil."},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib97","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.clinthera.2015.02.028","article-title":"Examining the time to therapeutic effect of pregabalin in spinal cord injury patients with neuropathic pain","volume":"37","author":"Cardenas","year":"2015","journal-title":"Clin. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib98","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00213-004-2095-0","article-title":"Effects of the antidepressant trazodone, a 5-HT 2A\/2C receptor antagonist, on dopamine-dependent behaviors in rats","volume":"179","author":"Balsara","year":"2005","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib99","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/PRS.0b013e318219c171","article-title":"The levels of evidence and their role in evidence-based medicine","volume":"128","author":"Burns","year":"2011","journal-title":"Plast. Reconstr. Surg."},{"issue":"12","key":"10.1016\/j.biopha.2021.111563_bib100","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.apmr.2007.07.038","article-title":"Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury","volume":"88","author":"Rintala","year":"2007","journal-title":"Arch. Phys. Med. Rehabil."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib101","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.pain.2010.09.005","article-title":"Duloxetine in patients with central neuropathic pain caused by spinal cord injury or stroke: a randomized, double-blind, placebo-controlled trial","volume":"152","author":"Vranken","year":"2011","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib102","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/sc.2013.146","article-title":"Anticonvulsant medication use for the management of pain following spinal cord injury: systematic review and effectiveness analysis","volume":"52","author":"Guy","year":"2014","journal-title":"Spinal Cord"},{"key":"10.1016\/j.biopha.2021.111563_bib103","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/eujp.2001.0323","article-title":"Neurobiology of neuropathic pain: mode of action of anticonvulsants","volume":"6","author":"Dickenson","year":"2002","journal-title":"Eur. J. Pain"},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib104","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/j.1532-2149.2013.00416.x","article-title":"Electrophysiological characterization of spinal neuron sensitization by elevated calcium channel alpha\u20102\u2013delta\u20101 subunit protein","volume":"18","author":"Zhou","year":"2014","journal-title":"Eur. J. Pain"},{"issue":"12","key":"10.1016\/j.biopha.2021.111563_bib105","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1097\/j.pain.0000000000001040","article-title":"Multiple sites and actions of gabapentin-induced relief of ongoing experimental neuropathic pain","volume":"158","author":"Bannister","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2021.111563_bib106","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-540-79090-7_1","article-title":"Neuropathic pain: a clinical perspective","author":"Baron","year":"2009","journal-title":"Sens. Nerves"},{"issue":"10","key":"10.1016\/j.biopha.2021.111563_bib107","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1152\/jn.00168.2014","article-title":"Analysis of the long-term actions of gabapentin and pregabalin in dorsal root ganglia and substantia gelatinosa","volume":"112","author":"Biggs","year":"2014","journal-title":"J. Neurophysiol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib108","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/10790268.2002.11753609","article-title":"Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized, double-blind, crossover trial","volume":"25","author":"Tai","year":"2002","journal-title":"J. Spinal Cord Med."},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib109","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/01.BRS.0000048464.57011.00","article-title":"Gabapentin effect on neuropathic pain compared among patients with spinal cord injury and different durations of symptoms","volume":"28","author":"Ahn","year":"2003","journal-title":"Spine"},{"issue":"6","key":"10.1016\/j.biopha.2021.111563_bib110","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/sj.sc.3101300","article-title":"Gabapentin for neuropathic pain following spinal cord injury","volume":"40","author":"To","year":"2002","journal-title":"Spinal Cord"},{"issue":"7","key":"10.1016\/j.biopha.2021.111563_bib111","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/01.BRS.0000112068.16108.3A","article-title":"Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury","volume":"29","author":"Levendoglu","year":"2004","journal-title":"Spine"},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib112","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2217\/pmt.13.35","article-title":"Pregabalin for the management of neuropathic pain in spinal cord injury","volume":"3","author":"Dalal","year":"2013","journal-title":"Pain Manag."},{"issue":"12","key":"10.1016\/j.biopha.2021.111563_bib113","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1111\/bph.13789","article-title":"Calcium channel modulation as a target in chronic pain control","volume":"175","author":"Patel","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib114","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/bja\/aes120","article-title":"Effects of pregabalin on the activity of glutamate transporter type 3","volume":"109","author":"Ryu","year":"2012","journal-title":"Br. J. Anaesth."},{"issue":"10","key":"10.1016\/j.biopha.2021.111563_bib115","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1212\/01.wnl.0000244422.45278.ff","article-title":"Pregabalin in central neuropathic pain associated with spinal cord injury A placebo-controlled trial","volume":"67","author":"Siddall","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2021.111563_bib116","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2147\/JPR.S97770","article-title":"Pain relief and functional improvement in patients with neuropathic pain associated with spinal cord injury: an exploratory analysis of pregabalin clinical trials","volume":"9","author":"Sadosky","year":"2016","journal-title":"J. Pain Res."},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib117","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/sc.2010.170","article-title":"Osteopathic manipulative treatment is effective on pain control associated to spinal cord injury","volume":"49","author":"Arienti","year":"2011","journal-title":"Spinal Cord"},{"issue":"6","key":"10.1016\/j.biopha.2021.111563_bib118","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1212\/WNL.0b013e318281546b","article-title":"A randomized trial of pregabalin in patients with neuropathic pain due to spinal cord injury","volume":"80","author":"Cardenas","year":"2013","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/j.biopha.2021.111563_bib119","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pain.2007.06.033","article-title":"Pregabalin in patients with central neuropathic pain: a randomized, double-blind, placebo-controlled trial of a flexible-dose regimen","volume":"136","author":"Vranken","year":"2008","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib120","doi-asserted-by":"crossref","first-page":"245","DOI":"10.36076\/ppj.2010\/13\/245","article-title":"Multi-day low dose ketamine infusion as adjuvant to oral gabapentin in spinal cord injury related chronic pain: a prospective, randomized, double blind trial","volume":"13","author":"Amr","year":"2010","journal-title":"Pain Physician"},{"key":"10.1016\/j.biopha.2021.111563_bib121","first-page":"1","article-title":"Gabapentin vs. pregabalin for the treatment of neuropathic pain in patients with spinal cord injury: a crossover study","volume":"61","author":"Yilmaz","year":"2014","journal-title":"Turk. J. Phys. Med. Rehabil."},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib122","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.apmr.2010.01.022","article-title":"A systematic review of pharmacologic treatments of pain after spinal cord injury","volume":"91","author":"Teasell","year":"2010","journal-title":"Arch. Phys. Med. Rehabil."},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib123","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0304-3959(01)00484-5","article-title":"Lamotrigine in spinal cord injury pain: a randomized controlled trial","volume":"96","author":"Finnerup","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2021.111563_bib124","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0197-0186(00)00013-9","article-title":"Mechanisms of action of valproate: a commentatory","volume":"37","author":"Johannessen","year":"2000","journal-title":"Neurochem. Int."},{"issue":"8","key":"10.1016\/j.biopha.2021.111563_bib125","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/sc.1994.89","article-title":"Valproate for treatment of chronic central pain after spinal cord injury. A double-blind cross-over study","volume":"32","author":"Drewes","year":"1994","journal-title":"Spinal Cord"},{"issue":"9","key":"10.1016\/j.biopha.2021.111563_bib126","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1179\/1743132815Y.0000000057","article-title":"Contusive spinal cord injury up regulates mu-opioid receptor (mor) gene expression in the brain and down regulates its expression in the spinal cord: possible implications in spinal cord injury research","volume":"37","author":"Michael","year":"2015","journal-title":"Neurol. Res."},{"issue":"7","key":"10.1016\/j.biopha.2021.111563_bib127","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ejpain.2010.11.018","article-title":"Dynamic temporal and spatial regulation of mu opioid receptor expression in primary afferent neurons following spinal nerve injury","volume":"15","author":"Lee","year":"2011","journal-title":"Eur. J. Pain"},{"issue":"6","key":"10.1016\/j.biopha.2021.111563_bib128","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1227\/00006123-199512000-00007","article-title":"Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation","volume":"37","author":"Eide","year":"1995","journal-title":"Neurosurgery"},{"key":"10.1016\/j.biopha.2021.111563_bib129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/2480689","article-title":"Neuronal-glial interactions maintain chronic neuropathic pain after spinal cord injury","volume":"2017","author":"Gwak","year":"2017","journal-title":"Neural Plast."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib130","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.bbi.2010.10.018","article-title":"An IL-1 receptor antagonist blocks a morphine-induced attenuation of locomotor recovery after spinal cord injury","volume":"25","author":"Hook","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.biopha.2021.111563_bib131","doi-asserted-by":"crossref","DOI":"10.1186\/1744-8069-8-43","article-title":"Contribution of microglia and astrocytes to the central sensitization, inflammatory and neuropathic pain in the juvenile rat","volume":"8","author":"Ikeda","year":"2012","journal-title":"Mol. Pain"},{"issue":"1\u20132","key":"10.1016\/j.biopha.2021.111563_bib132","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0006-8993(92)90952-6","article-title":"N-methyl-D-aspartate (NMDA) and opioid receptors mediate dynorphin-induced spinal cord injury: behavioral and histological studies","volume":"580","author":"Bakshi","year":"1992","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib133","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0022-3565(24)38100-5","article-title":"Response surface analysis of synergism between morphine and clonidine","volume":"289","author":"Tallarida","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib134","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1212\/WNL.58.4.554","article-title":"Effects of IV morphine in central pain A randomized placebo-controlled study","volume":"58","author":"Attal","year":"2002","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib135","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/AJP.0b013e31818a744d","article-title":"Tramadol in neuropathic pain after spinal cord injury: a randomized, double-blind, placebo-controlled trial","volume":"25","author":"Norrbrink","year":"2009","journal-title":"Clin. J. Pain"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib136","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/sc.2010.101","article-title":"Oxycodone improves pain control and quality of life in anticonvulsant-pretreated spinal cord-injured patients with neuropathic pain","volume":"49","author":"Barrera-Chacon","year":"2011","journal-title":"Spinal Cord"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib137","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev-neuro-080317-061522","article-title":"Endogenous and exogenous opioids in pain","volume":"41","author":"Corder","year":"2018","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.biopha.2021.111563_bib138","doi-asserted-by":"crossref","first-page":"145","DOI":"10.36076\/ppj.2011\/14\/145","article-title":"A comprehensive review of opioid-induced hyperalgesia","volume":"14","author":"Lee","year":"2011","journal-title":"Pain Physician"},{"issue":"48","key":"10.1016\/j.biopha.2021.111563_bib139","doi-asserted-by":"crossref","first-page":"11145","DOI":"10.1523\/JNEUROSCI.3768-05.2005","article-title":"Expression of spinal NMDA receptor and PKC\u03b3 after chronic morphine is regulated by spinal glucocorticoid receptor","volume":"25","author":"Lim","year":"2005","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib140","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0304-3959(02)00422-0","article-title":"Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy","volume":"100","author":"Mao","year":"2002","journal-title":"Pain"},{"issue":"10","key":"10.1016\/j.biopha.2021.111563_bib141","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/PHM.0b013e3181f1c4ec","article-title":"Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study","volume":"89","author":"Rintala","year":"2010","journal-title":"Am. J. Phys. Med. Rehabil."},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib142","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1089\/neu.2016.4507","article-title":"Neurobiological effects of morphine after spinal cord injury","volume":"34","author":"Hook","year":"2016","journal-title":"J. Neurotrauma"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41394-018-0095-2","article-title":"Opioids should not be prescribed for chronic pain after spinal cord injury","volume":"4","author":"Bryce","year":"2018","journal-title":"Spinal Cord Ser. Cases"},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib144","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/2192568217735804","article-title":"Worldwide steroid prescription for acute spinal cord injury","volume":"8","author":"Falavigna","year":"2018","journal-title":"Glob. Spine J."},{"issue":"10","key":"10.1016\/j.biopha.2021.111563_bib145","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1089\/neu.2016.4473","article-title":"Methylprednisolone for the treatment of patients with acute spinal cord injuries: a propensity score-matched cohort study from a Canadian multi-center spinal cord injury registry","volume":"33","author":"Hall","year":"2016","journal-title":"J. Neurotrauma"},{"issue":"8","key":"10.1016\/j.biopha.2021.111563_bib146","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s00415-016-8183-3","article-title":"Patient-reported adverse effects of high-dose intravenous methylprednisolone treatment: a prospective web-based multi-center study in multiple sclerosis patients with a relapse","volume":"263","author":"Jongen","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.biopha.2021.111563_bib147","series-title":"Progress Brain Research","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0079-6123(06)61015-7","article-title":"Update on the treatment of spinal cord injury","author":"Baptiste","year":"2007"},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib148","first-page":"149","article-title":"Effects of combining methylprednisolone with magnesium sulfate on neuropathic pain and functional recovery following spinal cord injury in male rats","volume":"53","author":"Farsi","year":"2015","journal-title":"Acta Med. Iran."},{"key":"10.1016\/j.biopha.2021.111563_bib149","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.smim.2014.03.004","article-title":"Glucocorticoids and macrophage migration inhibitory factor (MIF) are neuroendocrine modulators of inflammation and neuropathic pain after spinal cord injury","volume":"26","author":"Lerch","year":"2014","journal-title":"Semin. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2021.111563_bib150","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/nrd1107","article-title":"Neurotrophic factors as novel therapeutics for neuropathic pain","volume":"2","author":"Sah","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib151","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1523\/JNEUROSCI.4127-04.2005","article-title":"Central glucocorticoid receptors modulate the expression and function of spinal NMDA receptors after peripheral nerve injury","volume":"25","author":"Wang","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2021.111563_bib152","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ygcen.2012.10.006","article-title":"Role of glucocorticoid in developmental programming: evidence from zebrafish","volume":"181","author":"Nesan","year":"2013","journal-title":"Gen. Comp. Endocrinol."},{"issue":"10","key":"10.1016\/j.biopha.2021.111563_bib153","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078316","article-title":"Deep sequencing identification of novel glucocorticoid-responsive miRNAs in apoptotic primary lymphocytes","volume":"8","author":"Smith","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib154","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.tem.2012.11.005","article-title":"The five Rs of glucocorticoid action during inflammation: ready, reinforce, repress, resolve, and restore","volume":"24","author":"Busillo","year":"2013","journal-title":"Trends Endocrinol. Metab."},{"issue":"43","key":"10.1016\/j.biopha.2021.111563_bib155","doi-asserted-by":"crossref","first-page":"17591","DOI":"10.1073\/pnas.1209411109","article-title":"Glucocorticoids regulate arrestin gene expression and redirect the signaling profile of G protein-coupled receptors","volume":"109","author":"Oakley","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"18","key":"10.1016\/j.biopha.2021.111563_bib156","doi-asserted-by":"crossref","first-page":"7877","DOI":"10.1523\/JNEUROSCI.4705-12.2013","article-title":"Glucocorticoid signaling in myeloid cells worsens acute CNS injury and inflammation","volume":"33","author":"Sorrells","year":"2013","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib157","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuron.2009.09.032","article-title":"The stressed CNS: when glucocorticoids aggravate inflammation","volume":"64","author":"Sorrells","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2021.111563_bib158","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.smim.2014.03.004","article-title":"Glucocorticoids and macrophage migration inhibitory factor (MIF) are neuroendocrine modulators of inflammation and neuropathic pain after spinal cord injury","author":"Lerch","year":"2014","journal-title":"Semin. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib159","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1210\/er.2002-0006","article-title":"The interplay between the glucocorticoid receptor and nuclear factor-\u03baB or activator protein-1: molecular mechanisms for gene repression","volume":"24","author":"De Bosscher","year":"2003","journal-title":"Endocr. Rev."},{"issue":"16","key":"10.1016\/j.biopha.2021.111563_bib160","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids\u2014New mechanisms for old drugs","volume":"353","author":"Rhen","year":"2005","journal-title":"New Engl. J. Med."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib161","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.neuroscience.2008.08.067","article-title":"Selective stimulation of either tumor necrosis factor receptor differentially induces pain behavior in vivo and ectopic activity in sensory neurons in vitro","volume":"157","author":"Sch\u00e4fers","year":"2008","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib162","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000330195","article-title":"Neuronal injury marker ATF-3 is induced in primary afferent neurons of monoarthritic rats","volume":"19","author":"Nascimento","year":"2011","journal-title":"Neurosignals"},{"issue":"11","key":"10.1016\/j.biopha.2021.111563_bib163","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/nn1992","article-title":"The neuropathic pain triad: neurons, immune cells and glia","volume":"10","author":"Scholz","year":"2007","journal-title":"Nat. Neurosci."},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib164","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1213\/ANE.0000000000000161","article-title":"The effects of glucocorticoids on neuropathic pain: a review with emphasis on intrathecal methylprednisolone acetate delivery","volume":"118","author":"Rijsdijk","year":"2014","journal-title":"Anesth. Analg."},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib165","first-page":"324","article-title":"Relationship between the interval before high-dose methylprednisolone administration and chronic pain in traumatic spinal cord injury","volume":"16","author":"Wu","year":"2011","journal-title":"Neurosciences"},{"issue":"20","key":"10.1016\/j.biopha.2021.111563_bib166","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM199005173222001","article-title":"A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury: results of the second national acute spinal cord injury study","volume":"322","author":"Bracken","year":"1990","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.biopha.2021.111563_bib167","first-page":"275","article-title":"Erythropoietin plus methylprednisolone or methylprednisolone in the treatment of acute spinal cord injury: a preliminary report","author":"Alibai","year":"2014","journal-title":"Acta Med. Iran."},{"issue":"7","key":"10.1016\/j.biopha.2021.111563_bib168","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0020-1383(93)90149-Z","article-title":"Application of dexamethasone in the treatment of acute spinal cord injury","volume":"24","author":"Kiwerski","year":"1993","journal-title":"Injury"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib169","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/neu.2010.1539","article-title":"Antinociceptive effect of riluzole in rats with neuropathic spinal cord injury pain","volume":"28","author":"Hama","year":"2011","journal-title":"J. Neurotrauma"},{"issue":"12","key":"10.1016\/j.biopha.2021.111563_bib170","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/bph.14215","article-title":"Recent advances in targeting ion channels to treat chronic pain","volume":"175","author":"Stevens","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib171","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pain.2007.07.026","article-title":"The roles of sodium channels in nociception: implications for mechanisms of pain","volume":"131","author":"Cummins","year":"2007","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib172","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5214\/ans.0972.7531.210305","article-title":"Pathogenesis of spinal cord injury induced edema and neuropathic pain: expression of multiple isoforms of wnk1","volume":"21","author":"Ahmed","year":"2014","journal-title":"Ann. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib173","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1749-6632.2010.05462.x","article-title":"Role of NKCC1 and KCC2 in the development of chronic neuropathic pain following spinal cord injury","volume":"1198","author":"Hasbargen","year":"2010","journal-title":"Ann. N.Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2021.111563_bib174","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1089\/neu.2016.4789","article-title":"Activation of KCNQ Channels suppresses spontaneous activity in dorsal root ganglion neurons and reduces chronic pain after spinal cord injury","volume":"34","author":"Wu","year":"2017","journal-title":"J. Neurotrauma"},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib175","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1254\/jphs.12080SC","article-title":"Single application of A2 NTX, a botulinum toxin A2 subunit, prevents chronic pain over long periods in both diabetic and spinal cord injury\u2013induced neuropathic pain models","volume":"119","author":"Ma","year":"2012","journal-title":"J. Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib176","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.neuropharm.2006.05.015","article-title":"Retigabine-induced population primary afferent hyperpolarisation in vitro","volume":"51","author":"Rivera-Arconada","year":"2006","journal-title":"Neuropharmacology"},{"issue":"18","key":"10.1016\/j.biopha.2021.111563_bib177","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1523\/JNEUROSCI.23-18-07227.2003","article-title":"KCNQ\/M currents in sensory neurons: significance for pain therapy","volume":"23","author":"Passmore","year":"2003","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib178","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1124\/jpet.119.264010","article-title":"Enhancing KCNQ channel activity improves neurobehavioral recovery after spinal cord injury","volume":"373","author":"Wu","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib179","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.pbb.2010.08.006","article-title":"Antinociceptive effect of ambroxol in rats with neuropathic spinal cord injury pain","volume":"97","author":"Hama","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"7","key":"10.1016\/j.biopha.2021.111563_bib180","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.3390\/toxins7072435","article-title":"Botulinum toxin as a pain killer: players and actions in antinociception","volume":"7","author":"Kim","year":"2015","journal-title":"Toxins"},{"issue":"11","key":"10.1016\/j.biopha.2021.111563_bib181","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/AJP.0b013e31827eafff","article-title":"Subcutaneous and perineural botulinum toxin type A for neuropathic pain: a descriptive review","volume":"29","author":"Fabregat","year":"2013","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.biopha.2021.111563_bib182","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s13311-018-0633-4","article-title":"Neuropathic pain after spinal cord injury: challenges and research perspectives","volume":"15","author":"Shiao","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"10","key":"10.1016\/j.biopha.2021.111563_bib183","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1113\/JP270474","article-title":"Decreases in mitochondrial reactive oxygen species initiate GABAA receptor\u2010mediated electrical suppression in anoxia\u2010tolerant turtle neurons","volume":"593","author":"Hogg","year":"2015","journal-title":"J. Physiol."},{"key":"10.1016\/j.biopha.2021.111563_bib184","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9185368","article-title":"Impaired autophagy of GABAergic interneurons in neuropathic pain","volume":"2018","author":"Yin","year":"2018","journal-title":"Pain Res. Manag."},{"issue":"15","key":"10.1016\/j.biopha.2021.111563_bib185","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.1523\/JNEUROSCI.22-15-06724.2002","article-title":"Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord","volume":"22","author":"Moore","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2021.111563_bib186","doi-asserted-by":"crossref","DOI":"10.1177\/1744806919847366","article-title":"The etiological contribution of GABAergic plasticity to the pathogenesis of neuropathic pain","volume":"15","author":"Li","year":"2019","journal-title":"Mol. Pain"},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib187","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/01.j.pain.0000460354.09622.ec","article-title":"Induction of long-term potentiation and long-term depression is cell-type specific in the spinal cord","volume":"156","author":"Kim","year":"2015","journal-title":"Pain"},{"issue":"17","key":"10.1016\/j.biopha.2021.111563_bib188","doi-asserted-by":"crossref","first-page":"6617","DOI":"10.1523\/JNEUROSCI.21-17-06617.2001","article-title":"Tumor necrosis factor receptor deletion reduces nuclear factor-\u03baB activation, cellular inhibitor of apoptosis protein 2 expression, and functional recovery after traumatic spinal cord injury","volume":"21","author":"Kim","year":"2001","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib189","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1471-4159.2007.04787.x","article-title":"Molecular and cellular characterization of the age\u2010related neuroinflammatory processes occurring in normal rat hippocampus: potential relation with the loss of somatostatin GABAergic neurons","volume":"103","author":"Gavil\u00e1n","year":"2007","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib190","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/jnr.21508","article-title":"Nuclear factor\u2010\u03baB decoy amelioration of spinal cord injury\u2010induced inflammation and behavior outcomes","volume":"86","author":"Rafati","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.biopha.2021.111563_bib191","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.brainresbull.2018.05.013","article-title":"Analgesic effect of intrathecal baclofen bolus on neuropathic pain in spinal cord injury patients","volume":"140","author":"Kumru","year":"2018","journal-title":"Brain Res. Bull."},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib192","first-page":"S15","article-title":"Pharmacologic management of spinal spasticity","volume":"5","author":"Herman","year":"1991","journal-title":"J. Neurol. Rehabil."},{"issue":"6683","key":"10.1016\/j.biopha.2021.111563_bib193","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/30748","article-title":"Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A","volume":"393","author":"Das","year":"1998","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib194","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1471-4159.2000.0750174.x","article-title":"Changes in NMDA receptor subunit expression in response to contusive spinal cord injury","volume":"75","author":"Grossman","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2021.111563_bib195","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.expneurol.2008.10.018","article-title":"Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain injury","volume":"215","author":"Qu.","year":"2009","journal-title":"Exp. Neurol."},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib196","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3171\/jns.1995.83.5.0884","article-title":"Role of N-methyl-D-aspartate receptor in acute spinal cord injury","volume":"83","author":"Yanase","year":"1995","journal-title":"J. Neurosurg."},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib197","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.3892\/etm.2014.1878","article-title":"Supression of chronic central pain by superoxide dismutase in rats with spinal cord injury: inhibition of the NMDA receptor implicated","volume":"8","author":"Xie","year":"2014","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib198","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.expneurol.2010.02.012","article-title":"Ionotropic glutamate receptors contribute to maintained neuronal hyperexcitability following spinal cord injury in rats","volume":"224","author":"Leem","year":"2010","journal-title":"Exp. Neurol."},{"issue":"9","key":"10.1016\/j.biopha.2021.111563_bib199","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1016\/j.celrep.2018.04.107","article-title":"NMDA receptor activation underlies the loss of spinal dorsal horn neurons and the transition to persistent pain after peripheral nerve injury","volume":"23","author":"Inquimbert","year":"2018","journal-title":"Cell Rep."},{"issue":"8","key":"10.1016\/j.biopha.2021.111563_bib200","doi-asserted-by":"crossref","first-page":"E746","DOI":"10.1073\/pnas.1300083110","article-title":"Alleviation of chronic pain following rat spinal cord compression injury with multimodal actions of huperzine A","volume":"110","author":"Yu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.biopha.2021.111563_bib201","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.neulet.2018.03.030","article-title":"Astaxanthin ameliorates behavioral and biochemical alterations in in-vitro and in-vivo model of neuropathic pain","volume":"674","author":"Sharma","year":"2018","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib202","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.pain.2012.02.003","article-title":"Effect of NMDA NR2B antagonist on neuropathic pain in two spinal cord injury models","volume":"153","author":"Kim","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2021.111563_bib203","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1146\/annurev.pharmtox.47.120505.105311","article-title":"Cell signaling and neuronal death","volume":"47","author":"Hara","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib204","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nn835","article-title":"Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways","volume":"5","author":"Hardingham","year":"2002","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib205","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s11011-014-9570-z","article-title":"Estradiol attenuates spinal cord injury-related central pain by decreasing glutamate levels in thalamic VPL nucleus in male rats","volume":"29","author":"Naderi","year":"2014","journal-title":"Metab. Brain Dis."},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib206","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.neures.2013.01.010","article-title":"Estradiol attenuates spinal cord injury-induced pain by suppressing microglial activation in thalamic VPL nuclei of rats","volume":"75","author":"Saghaei","year":"2013","journal-title":"Neurosci. Res."},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib207","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1586\/ecp.11.17","article-title":"Targeting N-methyl-D-aspartate receptors for treatment of neuropathic pain","volume":"4","author":"Zhou","year":"2011","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111563_bib208","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.brainresbull.2018.09.011","article-title":"Astaxanthin attenuates neuroinflammation contributed to the neuropathic pain and motor dysfunction following compression spinal cord injury","volume":"143","author":"Fakhri","year":"2018","journal-title":"Brain Res. Bull."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib209","doi-asserted-by":"crossref","first-page":"101","DOI":"10.32598\/ppj.24.2.20","article-title":"The effects of intrathecal ketamine on improving sensory-motor function in a rat model of compression spinal cord injury","volume":"24","author":"Fakhri","year":"2020","journal-title":"Physiol. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib210","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/SPC.0000000000000207","article-title":"What do monoamines do in pain modulation?","volume":"10","author":"Bannister","year":"2016","journal-title":"Curr. Opin. Support. Palliat. Care"},{"issue":"1\u20133","key":"10.1016\/j.biopha.2021.111563_bib211","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejphar.2006.08.064","article-title":"Spinal and pontine \u03b12-adrenoceptors have opposite effects on pain-related behavior in the neuropathic rat","volume":"551","author":"Wei","year":"2006","journal-title":"Eur. J. Pharmacol."},{"issue":"14","key":"10.1016\/j.biopha.2021.111563_bib212","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1111\/bph.14580","article-title":"Spinal \u03b12\u2013adrenoceptors and neuropathic pain modulation; therapeutic target","volume":"176","author":"Bahari","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib213","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.pharmthera.2009.04.001","article-title":"Pharmacological profiles of alpha 2 adrenergic receptor agonists identified using genetically altered mice and isobolographic analysis","volume":"123","author":"Fairbanks","year":"2009","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib214","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pneurobio.2006.08.001","article-title":"Noradrenergic pain modulation","volume":"80","author":"Pertovaara","year":"2006","journal-title":"Prog. Neurobiol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-8-31","article-title":"Selective adenosine A 2A receptor agonists and antagonists protect against spinal cord injury through peripheral and central effects","volume":"8","author":"Paterniti","year":"2011","journal-title":"J. Neuroinflamm."},{"issue":"6","key":"10.1016\/j.biopha.2021.111563_bib216","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0301-0082(02)00009-6","article-title":"Descending control of pain","volume":"66","author":"Millan","year":"2002","journal-title":"Prog. Neurobiol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib217","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1113\/jphysiol.2003.054932","article-title":"Actions of noradrenaline on substantia gelatinosa neurones in the rat spinal cord revealed by in vivo patch recording","volume":"555","author":"Sonohata","year":"2004","journal-title":"J. Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib218","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/ALN.0b013e3181de6d2c","article-title":"Spinal \u03b12-adrenoceptor-mediated analgesia in neuropathic pain reflects brain-derived nerve growth factor and changes in spinal cholinergic neuronal function","volume":"113","author":"Hayashida","year":"2010","journal-title":"Anesthesiol.: J. Am. Soc. Anesthesiol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib219","first-page":"73","article-title":"Selective adenosine A (2a) receptor agonists reduce the apoptosis in an experimental model of spinal cord trauma","volume":"24","author":"Genovese","year":"2010","journal-title":"J. Biol. Regul. Homeost. Agents"},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib220","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.neuroscience.2006.05.014","article-title":"Mouse spinal cord compression injury is reduced by either activation of the adenosine A2A receptor on bone marrow\u2013derived cells or deletion of the A2A receptor on non-bone marrow\u2013derived cells","volume":"141","author":"Li","year":"2006","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib221","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S0885-3924(00)00202-5","article-title":"Clinical guidelines for intraspinal infusion: report of an expert panel","volume":"20","author":"Bennett","year":"2000","journal-title":"J. Pain. Symptom Manag."},{"issue":"12","key":"10.1016\/j.biopha.2021.111563_bib222","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/sc.2012.83","article-title":"Sexual function and autonomic dysreflexia in men with spinal cord injuries: how should we treat?","volume":"50","author":"Courtois","year":"2012","journal-title":"Spinal Cord"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib223","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0885-3924(03)00144-1","article-title":"Long-term outcomes during treatment of chronic pain with intrathecal clonidine or clonidine\/opioid combinations","volume":"26","author":"Ackerman","year":"2003","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.biopha.2021.111563_bib224","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neulet.2017.04.011","article-title":"Dexmedetomidine confers neuroprotection against transient global cerebral ischemia\/reperfusion injury in rats by inhibiting inflammation through inactivation of the TLR-4\/NF-\u03baB pathway","volume":"649","author":"Kim","year":"2017","journal-title":"Neurosci. Lett."},{"issue":"21","key":"10.1016\/j.biopha.2021.111563_bib225","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1089\/neu.2017.5625","article-title":"Dexmedetomidine mitigates microglia-mediated neuroinflammation through upregulation of programmed cell death protein 1 in a rat spinal cord injury model","volume":"35","author":"He","year":"2018","journal-title":"J. Neurotrauma"},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib226","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cell.2005.10.041","article-title":"Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow","volume":"124","author":"Katayama","year":"2006","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib227","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.expneurol.2009.03.044","article-title":"Blockade of adrenoreceptors inhibits the splenic response to stroke","volume":"218","author":"Ajmo","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2021.111563_bib228","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.autneu.2014.01.006","article-title":"Autonomic regulation of cellular immune function","volume":"182","author":"Bellinger","year":"2014","journal-title":"Auton. Neurosci."},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib229","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0306-4522(98)00524-7","article-title":"Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study","volume":"90","author":"Hohmann","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2021.111563_bib230","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2011.07.031","article-title":"Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain","volume":"1412","author":"Hama","year":"2011","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib231","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1460-9568.2005.04206.x","article-title":"Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats","volume":"22","author":"Sagar","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.biopha.2021.111563_bib232","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.pnpbp.2015.03.008","article-title":"Cannabinoids to treat spinal cord injury","volume":"64","author":"Arevalo-Martin","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"5642","key":"10.1016\/j.biopha.2021.111563_bib233","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1088208","article-title":"CB1 cannabinoid receptors and on-demand defense against excitotoxicity","volume":"302","author":"Marsicano","year":"2003","journal-title":"Science"},{"issue":"22","key":"10.1016\/j.biopha.2021.111563_bib234","doi-asserted-by":"crossref","first-page":"8257","DOI":"10.1073\/pnas.1400988111","article-title":"A restricted population of CB1 cannabinoid receptors with neuroprotective activity","volume":"111","author":"Chiarlone","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib235","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/ejp.983","article-title":"Endocannabinoid activation of CB1 receptors contributes to long\u2010lasting reversal of neuropathic pain by repetitive spinal cord stimulation","volume":"21","author":"Sun","year":"2017","journal-title":"Eur. J. Pain"},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib236","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1460-9568.2009.07075.x","article-title":"Cannabinoid CB1 receptor facilitation of substance P release in the rat spinal cord, measured as neurokinin 1 receptor internalization","volume":"31","author":"Zhang","year":"2010","journal-title":"Eur. J. Neurosci."},{"issue":"6","key":"10.1016\/j.biopha.2021.111563_bib237","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.lfs.2005.05.055","article-title":"Cannabinoid signalling","volume":"78","author":"Demuth","year":"2006","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib238","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00406-018-0960-9","article-title":"Understanding the evidence for medical cannabis and cannabis-based medicines for the treatment of chronic non-cancer pain","volume":"269","author":"Campbell","year":"2019","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"6","key":"10.1016\/j.biopha.2021.111563_bib239","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jpain.2007.12.010","article-title":"A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain","volume":"9","author":"Wilsey","year":"2008","journal-title":"J. Pain"},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib240","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1037\/pha0000281","article-title":"Effects of cannabinoid administration for pain: a meta-analysis and meta-regression","volume":"27","author":"Yanes","year":"2019","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib241","first-page":"1","article-title":"Utilization of medicinal cannabis for pain by individuals with spinal cord injury","volume":"5","author":"Stillman","year":"2019","journal-title":"Spinal Cord Ser. Cases"},{"issue":"8","key":"10.1016\/j.biopha.2021.111563_bib242","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.apmr.2018.02.003","article-title":"Cannabis use in individuals with spinal cord injury or moderate to severe traumatic brain injury in Colorado","volume":"99","author":"Hawley","year":"2018","journal-title":"Arch. Phys. Med. Rehabil."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib243","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2340\/16501977-2105","article-title":"Cannabis use in persons with traumatic spinal cord injury in Denmark","volume":"49","author":"Andresen","year":"2017","journal-title":"J. Rehabil. Med."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib244","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41394-018-0096-1","article-title":"Cannabis shenanigans: advocating for the restoration of an effective treatment of pain following spinal cord injury","volume":"4","author":"Graves","year":"2018","journal-title":"Spinal Cord Ser. Cases"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib245","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1310\/sci2201-3","article-title":"Characteristics of individuals with spinal cord injury who use cannabis for therapeutic purposes","volume":"22","author":"Drossel","year":"2016","journal-title":"Top. Spinal Cord. Inj. Rehabil."},{"issue":"9","key":"10.1016\/j.biopha.2021.111563_bib246","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.364","article-title":"Cannabinoid CB2 receptor (CB2R) stimulation delays rubrospinal mitochondrial-dependent degeneration and improves functional recovery after spinal cord hemisection by ERK1\/2 inactivation","volume":"5","author":"Latini","year":"2014","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.biopha.2021.111563_bib247","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1089\/neu.2011.1853","article-title":"Modulation of inflammatory responses by a cannabinoid-2\u2013selective agonist after spinal cord injury","volume":"28","author":"Adhikary","year":"2011","journal-title":"J. Neurotrauma"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib248","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-017-0960-0","article-title":"Activation of dorsal horn cannabinoid CB2 receptor suppresses the expression of P2Y 12 and P2Y 13 receptors in neuropathic pain rats","volume":"14","author":"Niu","year":"2017","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2021.111563_bib249","series-title":"Targetting CB1 Cannabinoid Receptor for Neuroprotetion in Spinal Cord Injury","author":"Mukhopadhyay","year":"2011"},{"issue":"24","key":"10.1016\/j.biopha.2021.111563_bib250","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1097\/01.brs.0000245865.97424.b4","article-title":"B1 and TRPV-1 receptor genes and their relationship to hyperalgesia following spinal cord injury","volume":"31","author":"DomBourian","year":"2006","journal-title":"Spine"},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib251","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3171\/spi.2007.6.5.420","article-title":"Antihyperalgesic effects of vanilloid-1 and bradykinin-1 receptor antagonists following spinal cord injury in rats","volume":"6","author":"Rajpal","year":"2007","journal-title":"J. Neurosurg. Spine"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib252","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1038\/s41598-017-10426-7","article-title":"Expression and purification of the pain receptor TRPV1 for spectroscopic","volume":"7","author":"Velisetty","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2021.111563_bib253","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4324\/9781315152837-8","article-title":"TRP channels and pain","volume":"2","author":"Gonz\u00e1lez-Ram\u00edrez","year":"2017","journal-title":"Neurobiol. TRP Channels"},{"issue":"6","key":"10.1016\/j.biopha.2021.111563_bib254","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1464-410X.2003.04722.x","article-title":"Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan\u2010neuronal marker PGP9. 5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment","volume":"93","author":"Brady","year":"2004","journal-title":"BJU Int."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib255","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/sc.2013.136","article-title":"Changes in substance P and NK1 receptor immunohistochemistry following human spinal cord injury","volume":"52","author":"Leonard","year":"2014","journal-title":"Spinal Cord"},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib256","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1080\/10790268.2000.11753532","article-title":"Use of capsaicin in the treatment of radicular pain in spinal cord injury","volume":"23","author":"Sandford","year":"2000","journal-title":"J. Spinal Cord Med."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib257","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4155\/ppa.14.60","article-title":"Transient receptor potential ankyrin 1 (TRPA1) antagonists","volume":"4","author":"Preti","year":"2015","journal-title":"Pharm. Pat. Anal."},{"key":"10.1016\/j.biopha.2021.111563_bib258","unstructured":"J. Park, Acrolein as a Novel Therapeutic Target for Spinal Cord Injury Induced Neuropathic Pain, 2014."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib259","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/jnc.12628","article-title":"Neuroprotective role of hydralazine in rat spinal cord injury\u2010attenuation of acrolein\u2010mediated damage","volume":"129","author":"Park","year":"2014","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib260","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/jnc.12500","article-title":"Acrolein involvement in sensory and behavioral hypersensitivity following spinal cord injury in the rat","volume":"128","author":"Due","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2021.111563_bib261","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.4049\/jimmunol.0902474","article-title":"Transient receptor potential melastatin 2 is required for lipopolysaccharide-induced cytokine production in human monocytes","volume":"184","author":"Wehrhahn","year":"2010","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.biopha.2021.111563_bib262","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066410","article-title":"Involvement of TRPM2 in peripheral nerve injury-induced infiltration of peripheral immune cells into the spinal cord in mouse neuropathic pain model","volume":"8","author":"Isami","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2021.111563_bib263","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/aps.2018.31","article-title":"TRPM2: a candidate therapeutic target for treating neurological diseases","volume":"39","author":"Belrose","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib264","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1124\/jpet.109.164830","article-title":"Evidence for de novo synthesis of lysophosphatidic acid in the spinal cord through phospholipase A2 and autotaxin in nerve injury-induced neuropathic pain","volume":"333","author":"Ma","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2021.111563_bib265","series-title":"Basic & Clinical Pharmacology","first-page":"NY","author":"Katzung","year":"2015"},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib266","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1213\/01.ane.0000258060.89380.27","article-title":"Increased tumor necrosis factor-\u03b1 and prostaglandin E2 concentrations in the cerebrospinal fluid of rats with inflammatory hyperalgesia: the effects of analgesic drugs","volume":"104","author":"Bianchi","year":"2007","journal-title":"Anesth. Analg."},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib267","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0301-0082(00)00063-0","article-title":"Prostaglandins and cycloxygenases in the spinal cord","volume":"64","author":"Vanegas","year":"2001","journal-title":"Prog. Neurobiol."},{"issue":"22","key":"10.1016\/j.biopha.2021.111563_bib268","doi-asserted-by":"crossref","first-page":"9001","DOI":"10.1523\/JNEUROSCI.21-22-09001.2001","article-title":"Spinal prostaglandins are involved in the development but not the maintenance of inflammation-induced spinal hyperexcitability","volume":"21","author":"Vasquez","year":"2001","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib269","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0168-0102(01)00289-9","article-title":"Central and peripheral roles of prostaglandins in pain and their interactions with novel neuropeptides nociceptin and nocistatin","volume":"41","author":"Ito","year":"2001","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.biopha.2021.111563_bib270","doi-asserted-by":"crossref","DOI":"10.1186\/1744-8069-3-33","article-title":"p38 MAPK, microglial signaling, and neuropathic pain","volume":"3","author":"Ji","year":"2007","journal-title":"Mol. Pain"},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib271","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4110\/in.2012.12.2.41","article-title":"Glia as a link between neuroinflammation and neuropathic pain","volume":"12","author":"Jha","year":"2012","journal-title":"Immune Netw."},{"issue":"6","key":"10.1016\/j.biopha.2021.111563_bib272","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S1529-9430(01)00130-9","article-title":"Regional and temporal changes in prostaglandin E2 and thromboxane B2 concentrations after spinal cord injury","volume":"1","author":"Resnick","year":"2001","journal-title":"Spine J."},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib273","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/glia.20948","article-title":"Leukotriene synthases and the receptors induced by peripheral nerve injury in the spinal cord contribute to the generation of neuropathic pain","volume":"58","author":"Okubo","year":"2010","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib274","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0304-3959(94)90045-0","article-title":"Non-steroidal anti-inflammatory drugs and spinal nociceptive processing","volume":"59","author":"McCormack","year":"1994","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib275","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00441-012-1334-7","article-title":"Small-molecule-induced Rho-inhibition: NSAIDs after spinal cord injury","volume":"349","author":"Kopp","year":"2012","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.biopha.2021.111563_bib276","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.expneurol.2013.11.008","article-title":"Chronic ibuprofen administration reduces neuropathic pain but does not exert neuroprotection after spinal cord injury in adult rats","volume":"252","author":"Redondo-Castro","year":"2014","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib277","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-7-27","article-title":"TNF-\u03b1 and neuropathic pain-a review","volume":"7","author":"Leung","year":"2010","journal-title":"J. Neuroinflamm."},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib278","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1017\/S1740925X07000403","article-title":"Possible role of spinal astrocytes in maintaining chronic pain sensitization: review of current evidence with focus on bFGF\/JNK pathway","volume":"2","author":"Ji","year":"2006","journal-title":"Neuron Glia Biol."},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib279","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s10072-011-0599-z","article-title":"Role of TNF-alpha during central sensitization in preclinical studies","volume":"32","author":"Andrade","year":"2011","journal-title":"Neurol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib280","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2340\/16501977-0329","article-title":"Significant recovery of motor function in a patient with complete T7 paraplegia receiving etanercept","volume":"41","author":"Dinomais","year":"2009","journal-title":"J. Rehabil. Med."},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib281","first-page":"83","article-title":"Evaluation of TNF-\u03b1 and IL-6 release in the ventroposterolateral nucleus of the thalamus during central neuropathic pain induced by electrical injury of the spinothalamic tract in male rats: a microdialysis study","volume":"16","author":"Ghanbari","year":"2014","journal-title":"Pathobiol. Res."},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib282","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.3892\/etm.2013.1296","article-title":"Anti-interleukin-6 receptor antibody reduces neuropathic pain following spinal cord injury in mice","volume":"6","author":"Murakami","year":"2013","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.biopha.2021.111563_bib283","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neulet.2015.04.004","article-title":"Tumor necrosis factor-alpha is a potential diagnostic biomarker for chronic neuropathic pain after spinal cord injury","volume":"595","author":"Xu","year":"2015","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib284","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3171\/2010.12.SPINE10480","article-title":"Spatiotemporal CCR1, CCL3 (MIP-1\u03b1), CXCR4, CXCL12 (SDF-1\u03b1) expression patterns in a rat spinal cord injury model of posttraumatic neuropathic pain","volume":"14","author":"Knerlich-Lukoschus","year":"2011","journal-title":"J. Neurosurg. Spine"},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib285","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00019052-200206000-00021","article-title":"Targeting the host inflammatory response in traumatic spinal cord injury","volume":"15","author":"Bethea","year":"2002","journal-title":"Curr. Opin. Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib286","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11481-012-9394-8","article-title":"Resolvin E1 inhibits neuropathic pain and spinal cord microglial activation following peripheral nerve injury","volume":"8","author":"Xu","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib287","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/ana.20855","article-title":"Tumor necrosis factor\u2013\u03b1 contributes to below\u2010level neuropathic pain after spinal cord injury","volume":"59","author":"Peng","year":"2006","journal-title":"Ann. Neurol.: Off. J. Am. Neurol. Assoc. Child Neurol. Soc."},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib288","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1124\/jpet.105.097188","article-title":"Immunomodulatory effects of etanercept in an experimental model of spinal cord injury","volume":"316","author":"Genovese","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib289","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0306-4522(00)00574-1","article-title":"Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain","volume":"103","author":"Sweitzer","year":"2001","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.biopha.2021.111563_bib290","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.pain.2013.03.026","article-title":"Inhibition of IL-6 signaling: a novel therapeutic approach to treating spinal cord injury pain","volume":"154","author":"Guptarak","year":"2013","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib291","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/exnr.2000.7604","article-title":"Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat","volume":"168","author":"Plunkett","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2021.111563_bib292","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.phrs.2016.11.019","article-title":"Therapeutic implications of toll-like receptors in peripheral neuropathic pain","volume":"115","author":"Thakur","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2021.111563_bib293","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pharmthera.2017.10.006","article-title":"Toll-like receptors and their role in persistent pain","volume":"184","author":"Lacagnina","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"43","key":"10.1016\/j.biopha.2021.111563_bib294","doi-asserted-by":"crossref","first-page":"15450","DOI":"10.1523\/JNEUROSCI.3859-11.2011","article-title":"Spinal cord toll-like receptor 4 mediates inflammatory and neuropathic hypersensitivity in male but not female mice","volume":"31","author":"Sorge","year":"2011","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib295","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.expneurol.2011.09.038","article-title":"Toll-like receptors in chronic pain","volume":"234","author":"Nicotra","year":"2012","journal-title":"Exp. Neurol."},{"issue":"15","key":"10.1016\/j.biopha.2021.111563_bib296","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1089\/neu.2017.5519","article-title":"Persons with chronic spinal cord injury have decreased natural killer cell and increased toll-like receptor\/inflammatory gene expression","volume":"35","author":"Herman","year":"2018","journal-title":"J. Neurotrauma"},{"issue":"6640","key":"10.1016\/j.biopha.2021.111563_bib297","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/41131","article-title":"A human homologue of the Drosophila Toll protein signals activation of adaptive immunity","volume":"388","author":"Medzhitov","year":"1997","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib298","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1196\/annals.1281.023","article-title":"Regulation of CpG\u2010induced immune activation by suppressive oligodeoxynucleotides","volume":"1002","author":"Klinman","year":"2003","journal-title":"Ann. N.Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib299","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1089\/108729001317022241","article-title":"CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-\u03ba B activation","volume":"11","author":"Lenert","year":"2001","journal-title":"Antisense Nucleic Acid Drug Dev."},{"key":"10.1016\/j.biopha.2021.111563_bib300","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.4049\/jimmunol.1001241","article-title":"Painful pathways induced by TLR stimulation of dorsal root ganglion neurons","volume":"186","author":"Qi","year":"2011","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib301","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-26915-2","article-title":"A toll-like receptor 9 antagonist restores below-level glial glutamate transporter expression in the dorsal horn following spinal cord injury","volume":"8","author":"Pallottie","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2021.111563_bib302","doi-asserted-by":"crossref","first-page":"e529","DOI":"10.1016\/j.wneu.2019.08.086","article-title":"Effect of toll-like receptor 4\/myeloid differentiation factor 88 inhibition by salvianolic acid B on neuropathic pain after spinal cord injury in mice","volume":"132","author":"Wang","year":"2019","journal-title":"World Neurosurg."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib303","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1471-4159.2007.04524.x","article-title":"Toll\u2010like receptor (TLR)\u20102 and TLR\u20104 regulate inflammation, gliosis, and myelin sparing after spinal cord injury","volume":"102","author":"Kigerl","year":"2007","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.biopha.2021.111563_bib304","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1172\/JCI45414","article-title":"TLR3 deficiency impairs spinal cord synaptic transmission, central sensitization, and pruritus in mice","volume":"122","author":"Liu","year":"2012","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib305","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.brainresrev.2008.12.011","article-title":"MAP kinase and pain","volume":"60","author":"Ji","year":"2009","journal-title":"Brain Res. Rev."},{"issue":"8","key":"10.1016\/j.biopha.2021.111563_bib306","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.bbamcr.2006.10.005","article-title":"The MEK\/ERK cascade: from signaling specificity to diverse functions","volume":"1773","author":"Shaul","year":"2007","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell Res."},{"issue":"42","key":"10.1016\/j.biopha.2021.111563_bib307","doi-asserted-by":"crossref","first-page":"14006","DOI":"10.1523\/JNEUROSCI.1659-14.2014","article-title":"The Rac1 inhibitor NSC23766 suppresses CREB signaling by targeting NMDA receptor function","volume":"34","author":"Hou","year":"2014","journal-title":"J. Neurosci."},{"issue":"15","key":"10.1016\/j.biopha.2021.111563_bib308","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1523\/JNEUROSCI.5986-10.2011","article-title":"CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury","volume":"31","author":"Van Steenwinckel","year":"2011","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib309","first-page":"106","article-title":"Early intervention of ERK activation in the spinal cord can block initiation of peripheral nerve injury-induced neuropathic pain in rats","volume":"63","author":"Han","year":"2011","journal-title":"Sheng Li Xue Bao"},{"issue":"18","key":"10.1016\/j.biopha.2021.111563_bib310","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1097\/00001756-200212200-00021","article-title":"Activation of p38 MAP kinase in the rat dorsal root ganglia and spinal cord following peripheral inflammation and nerve injury","volume":"13","author":"Kim","year":"2002","journal-title":"Neuroreport"},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib311","first-page":"139","article-title":"cAMP response-element binding protein participates in the phosphorylated extracellular signal-regulate kinase mediated neuropathic pain","volume":"57","author":"Song","year":"2005","journal-title":"Sheng Li Xue Bao: Acta Physiol. Sin."},{"issue":"10","key":"10.1016\/j.biopha.2021.111563_bib312","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.ejpain.2011.04.005","article-title":"Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury","volume":"15","author":"Anand","year":"2011","journal-title":"Eur. J. Pain"},{"issue":"16","key":"10.1016\/j.biopha.2021.111563_bib313","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1523\/JNEUROSCI.0003-06.2006","article-title":"Activated microglia contribute to the maintenance of chronic pain after spinal cord injury","volume":"26","author":"Hains","year":"2006","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib314","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.expneurol.2008.05.025","article-title":"Activation of p38 MAP kinase is involved in central neuropathic pain following spinal cord injury","volume":"213","author":"Crown","year":"2008","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib315","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.expneurol.2006.01.003","article-title":"Increases in the activated forms of ERK 1\/2, p38 MAPK, and CREB are correlated with the expression of at-level mechanical allodynia following spinal cord injury","volume":"199","author":"Crown","year":"2006","journal-title":"Exp. Neurol."},{"issue":"16","key":"10.1016\/j.biopha.2021.111563_bib316","doi-asserted-by":"crossref","first-page":"12200","DOI":"10.1074\/jbc.275.16.12200","article-title":"Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures","volume":"275","author":"Stanciu","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2021.111563_bib317","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/j.1471-4159.2008.05743.x","article-title":"Protective effects of astaxanthin on 6\u2013hydroxydopamine\u2010induced apoptosis in human neuroblastoma SH\u2010SY5Y cells","volume":"107","author":"Ikeda","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2021.111563_bib318","article-title":"Effects of astaxanthin on sensory-motor function in a compression model of spinal cord injury: involvement of ERK and AKT signalling pathway","author":"Fakhri","year":"2018","journal-title":"Eur. J. Pain"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib319","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/jor.23328","article-title":"Rapamycin suppresses microglial activation and reduces the development of neuropathic pain after spinal cord injury","volume":"35","author":"Tateda","year":"2017","journal-title":"J. Orthop. Res."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib320","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3892\/etm.2013.1371","article-title":"MEK inhibition reduces glial scar formation and promotes the recovery of sensorimotor function in rats following spinal cord injury","volume":"7","author":"Lin","year":"2014","journal-title":"Exp. Ther. Med."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib321","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.expneurol.2012.05.014","article-title":"Inhibition of ROS-induced p38MAPK and ERK activation in microglia by acupuncture relieves neuropathic pain after spinal cord injury in rats","volume":"236","author":"Choi","year":"2012","journal-title":"Exp. Neurol."},{"issue":"49","key":"10.1016\/j.biopha.2021.111563_bib322","doi-asserted-by":"crossref","first-page":"13173","DOI":"10.1523\/JNEUROSCI.3142-08.2008","article-title":"Neuropathic pain memory is maintained by Rac1-regulated dendritic spine remodeling after spinal cord injury","volume":"28","author":"Tan","year":"2008","journal-title":"J. Neurosci."},{"issue":"46","key":"10.1016\/j.biopha.2021.111563_bib323","doi-asserted-by":"crossref","first-page":"10627","DOI":"10.1523\/JNEUROSCI.1947-05.2005","article-title":"Rac1 induces the clustering of AMPA receptors during spinogenesis","volume":"25","author":"Wiens","year":"2005","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.biopha.2021.111563_bib324","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1152\/jn.01057.2015","article-title":"Dendritic spine remodeling following early and late Rac1 inhibition after spinal cord injury: evidence for a pain biomarker","volume":"115","author":"Zhao","year":"2016","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.biopha.2021.111563_bib325","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.brainres.2010.04.010","article-title":"Expression and distribution of mTOR, p70S6K, 4E-BP1, and their phosphorylated counterparts in rat dorsal root ganglion and spinal cord dorsal horn","volume":"1336","author":"Xu","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2021.111563_bib326","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuroscience.2016.11.017","article-title":"Molecular neurobiology of mTOR","volume":"341","author":"Switon","year":"2017","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib327","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-015-0280-1","article-title":"Involvement of phosphatase and tensin homolog deleted from chromosome 10 in rodent model of neuropathic pain","volume":"12","author":"Huang","year":"2015","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib328","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1515\/tnsci-2016-0008","article-title":"Blocking mammalian target of rapamycin (mTOR) improves neuropathic pain evoked by spinal cord injury","volume":"7","author":"Wang","year":"2016","journal-title":"Transl. Neurosci."},{"key":"10.1016\/j.biopha.2021.111563_bib329","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pbb.2013.07.017","article-title":"Activation of mTOR in the spinal cord is required for pain hypersensitivity induced by chronic constriction injury in mice","volume":"111","author":"Zhang","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.biopha.2021.111563_bib330","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neuroscience.2019.03.052","article-title":"Alterations in the BDNF\u2013mTOR signaling pathway in the spinal cord contribute to hyperalgesia in a rodent model of chronic restraint stress","volume":"409","author":"Huang","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2021.111563_bib331","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neuroscience.2016.05.019","article-title":"Probucol inhibits neural cell apoptosis via inhibition of mTOR signaling pathway after spinal cord injury","volume":"329","author":"Zhou","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2021.111563_bib332","series-title":"The Effect of Sulfasalazine on Functional Recovery and Neuropathic Pain Following Spinal Cord Injury","author":"Atkins","year":"2011"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib333","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neulet.2012.01.030","article-title":"Targeting IKK\/NF-\u03baB pathway reduces infiltration of inflammatory cells and apoptosis after spinal cord injury in rats","volume":"511","author":"Han","year":"2012","journal-title":"Neurosci. Lett."},{"issue":"10","key":"10.1016\/j.biopha.2021.111563_bib334","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1128\/MCB.20.10.3655-3666.2000","article-title":"I\u03baB kinase \u03b1 (IKK\u03b1) regulation of IKK\u03b2 kinase activity","volume":"20","author":"Yamamoto","year":"2000","journal-title":"Mol. Cell. Biol."},{"issue":"9","key":"10.1016\/j.biopha.2021.111563_bib335","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.3390\/md13095750","article-title":"Astaxanthin as a potential neuroprotective agent for neurological diseases","volume":"13","author":"Wu","year":"2015","journal-title":"Mar. Drugs"},{"issue":"14","key":"10.1016\/j.biopha.2021.111563_bib336","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.3390\/molecules24142640","article-title":"The neuroprotective effects of astaxanthin: therapeutic targets and clinical perspective","volume":"24","author":"Fakhri","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2021.111563_bib337","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.lfs.2018.07.026","article-title":"Glucocorticoid receptor inhibit the activity of NF-\u03baB through p38 signaling pathway in spinal cord in the spared nerve injury rats","volume":"208","author":"Shao","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2021.111563_bib338","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3389\/fnins.2018.00690","article-title":"Inhibition of NF-\u03baB signaling pathway by resveratrol improves spinal cord injury","volume":"12","author":"Xu","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.biopha.2021.111563_bib339","first-page":"1","article-title":"Neuroprotection by Paeoniflorin against Nuclear Factor Kappa B-Induced Neuroinflammation on Spinal Cord","volume":"2018","author":"Wang","year":"2018","journal-title":"BioMed Res. Int."},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib340","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/j.1532-2149.2013.00376.x","article-title":"Progesterone reduces the expression of spinal cyclooxygenase\u20102 and inducible nitric oxide synthase and prevents allodynia in a rat model of central neuropathic pain","volume":"18","author":"Coronel","year":"2014","journal-title":"Eur. J. Pain"},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib341","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1159\/000480474","article-title":"Effect of shikonin on spinal cord injury in rats via regulation of HMGB1\/TLR4\/NF-kB signaling pathway","volume":"43","author":"Bi","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib342","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.expneurol.2012.04.018","article-title":"Macrophage migration inhibitory factor (MIF) is essential for inflammatory and neuropathic pain and enhances pain in response to stress","volume":"236","author":"Alexander","year":"2012","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib343","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00401-004-0853-z","article-title":"Up-regulation of macrophage migration-inhibitory factor expression after compression-induced spinal cord injury in rats","volume":"108","author":"Koda","year":"2004","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib344","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1286-4579(02)01560-5","article-title":"Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease","volume":"4","author":"Lue","year":"2002","journal-title":"Microbes Infect."},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib345","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/sj.icb.7100133","article-title":"Cunning factor: macrophage migration inhibitory factor as a redox\u2010regulated target","volume":"86","author":"Kudrin","year":"2008","journal-title":"Immunol. Cell Biol."},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib346","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/jcmm.13034","article-title":"Macrophage polarization: a key event in the secondary phase of acute spinal cord injury","volume":"21","author":"Kong","year":"2017","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib347","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00401-008-0476-x","article-title":"Deletion of macrophage migration inhibitory factor attenuates neuronal death and promotes functional recovery after compression-induced spinal cord injury in mice","volume":"117","author":"Nishio","year":"2009","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib348","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/jcbfm.2010.194","article-title":"Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke","volume":"31","author":"In\u00e1cio","year":"2011","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib349","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12974-019-1468-6","article-title":"Macrophage migration inhibitory factor facilitates prostaglandin E2 production of astrocytes to tune inflammatory milieu following spinal cord injury","volume":"16","author":"Zhang","year":"2019","journal-title":"J. Neuroinflamm."},{"issue":"8","key":"10.1016\/j.biopha.2021.111563_bib350","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jpsychires.2008.10.006","article-title":"Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer\u2019s disease","volume":"43","author":"Popp","year":"2009","journal-title":"J. Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib351","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.apmr.2014.10.021","article-title":"Elevated circulating levels of the pro-inflammatory cytokine macrophage migration inhibitory factor in individuals with acute spinal cord injury","volume":"96","author":"Bank","year":"2015","journal-title":"Arch. Phys. Med. Rehabil."},{"issue":"16","key":"10.1016\/j.biopha.2021.111563_bib352","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1089\/neu.2012.2474","article-title":"Neuroprotective effects of sulforaphane after contusive spinal cord injury","volume":"29","author":"Benedict","year":"2012","journal-title":"J. Neurotrauma"},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib353","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.54","article-title":"Minocycline selectively inhibits M1 polarization of microglia","volume":"4","author":"Kobayashi","year":"2013","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib354","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bph.12139","article-title":"Minocycline: far beyond an antibiotic","volume":"169","author":"Garrido\u2010Mesa","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib355","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.expneurol.2007.02.009","article-title":"The PPAR gamma agonist Pioglitazone improves anatomical and locomotor recovery after rodent spinal cord injury","volume":"205","author":"McTigue","year":"2007","journal-title":"Exp. Neurol."},{"issue":"8","key":"10.1016\/j.biopha.2021.111563_bib356","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1517\/14728222.2011.581231","article-title":"Targeting the peroxisome proliferator-activated receptors (PPARs) in spinal cord injury","volume":"15","author":"Esposito","year":"2011","journal-title":"Expert Opin. Ther. Targets"},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib357","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jpain.2013.12.007","article-title":"Systemic administration of propentofylline, ibudilast, and (+)-naltrexone each reverses mechanical allodynia in a novel rat model of central neuropathic pain","volume":"15","author":"Ellis","year":"2014","journal-title":"J. Pain"},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib358","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/ALN.0b013e31820a4bf3","article-title":"Spinal macrophage migration inhibitory factor is a major contributor to rodent neuropathic pain-like hypersensitivity","volume":"114","author":"Wang","year":"2011","journal-title":"J. Am. Soc. Anesthesiol."},{"issue":"6","key":"10.1016\/j.biopha.2021.111563_bib359","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1097\/ALN.0000000000000190","article-title":"Chemokine (CC motif) receptor 5 is an important pathological regulator in the development and maintenance of neuropathic pain","volume":"120","author":"Matsushita","year":"2014","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-018-1297-z","article-title":"Macrophage migration inhibitory factor facilitates production of CCL5 in astrocytes following rat spinal cord injury","volume":"15","author":"Zhou","year":"2018","journal-title":"J. Neuroinflamm."},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib361","doi-asserted-by":"crossref","first-page":"162","DOI":"10.5214\/ans.0972.7531.1118413","article-title":"Novel targets for spinal cord injury related neuropathic pain","volume":"18","author":"Ahmed","year":"2011","journal-title":"Ann. Neurosci."},{"issue":"39","key":"10.1016\/j.biopha.2021.111563_bib362","doi-asserted-by":"crossref","first-page":"9841","DOI":"10.1523\/JNEUROSCI.1993-06.2006","article-title":"Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury","volume":"26","author":"Hsu","year":"2006","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib363","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/sc.2016.104","article-title":"Exploratory study to suggest the possibility of MMP-8 and MMP-9 serum levels as early markers for remission after traumatic spinal cord injury","volume":"55","author":"Moghaddam","year":"2017","journal-title":"Spinal Cord"},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib364","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nm1723","article-title":"Distinct roles of matrix metalloproteases in the early-and late-phase development of neuropathic pain","volume":"14","author":"Kawasaki","year":"2008","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib365","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000443553","article-title":"Role of matrix metalloproteinases 2 in spinal cord injury-induced neuropathic pain","volume":"23","author":"Miranpuri","year":"2016","journal-title":"Ann. Neurosci."},{"key":"10.1016\/j.biopha.2021.111563_bib366","article-title":"Novel target for Spinal Cord Injury Neuropathic Pain","author":"Ahmed","year":"2012","journal-title":"Mini Rev. Med. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib367","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/s11064-011-0414-5","article-title":"Upregulation of inflammatory mediators in a model of chronic pain after spinal cord injury","volume":"36","author":"Sandhir","year":"2011","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib368","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000475896","article-title":"Folic Acid Modulates Matrix Metalloproteinase-2 Expression, Alleviates Neuropathic Pain, and Improves Functional Recovery in Spinal Cord-Injured Rats","volume":"24","author":"Miranpuri","year":"2017","journal-title":"Ann. Neurosci."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib369","doi-asserted-by":"crossref","first-page":"60","DOI":"10.5214\/ans.0972.7531.260205","article-title":"Folic acid modulates matrix metalloproteinase-9 expression following spinal cord injury","volume":"26","author":"Miranpuri","year":"2019","journal-title":"Ann. Neurosci."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib370","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s13311-011-0038-0","article-title":"Role of matrix metalloproteinases and therapeutic benefits of their inhibition in spinal cord injury","volume":"8","author":"Zhang","year":"2011","journal-title":"Neurotherapeutics"},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib371","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1124\/jpet.106.113472","article-title":"Thiazolidinedione class of peroxisome proliferator-activated receptor \u03b3 agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats","volume":"320","author":"Park","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2021.111563_bib372","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.nbd.2014.08.011","article-title":"Dynamic changes in pro-and anti-inflammatory cytokines in microglia after PPAR-\u03b3 agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson\u2019s disease","volume":"71","author":"Pisanu","year":"2014","journal-title":"Neurobiol. Dis."},{"issue":"7","key":"10.1016\/j.biopha.2021.111563_bib373","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2174\/1389450111314070003","article-title":"Targeting PPAR isoforms following CNS injury","volume":"14","author":"Yonutas","year":"2013","journal-title":"Curr. Drug Targets"},{"issue":"10","key":"10.1016\/j.biopha.2021.111563_bib374","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1161\/CIRCRESAHA.110.216523","article-title":"Control of macrophage activation and function by PPARs","volume":"106","author":"Chawla","year":"2010","journal-title":"Circ. Res."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2021.111563_bib375","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11010-017-3184-9","article-title":"Immunobiology of spinal cord injuries and potential therapeutic approaches","volume":"441","author":"Ahmed","year":"2018","journal-title":"Mol. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib376","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1517\/13543776.2016.1135901","article-title":"Modulators of microglia: a patent review","volume":"26","author":"Papa","year":"2016","journal-title":"Expert Opin. Ther. Pat."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib377","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-018-1182-9","article-title":"Procyanidins attenuate neuropathic pain by suppressing matrix metalloproteinase-9\/2","volume":"15","author":"Pan","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2021.111563_bib378","article-title":"Intrathecal administration of melatonin ameliorates the neuroinflammation-mediated sensory and motor dysfunction in a rat model of compression spinal cord injury","volume":"13","author":"Fakhri","year":"2020","journal-title":"Curr. Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib379","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1523\/JNEUROSCI.21-03-00999.2001","article-title":"Expression and localization of endothelin receptors: implications for the involvement of peripheral glia in nociception","volume":"21","author":"Pomonis","year":"2001","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.biopha.2021.111563_bib380","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1097\/01.ASN.0000141313.84470.4B","article-title":"Endothelin A receptor antagonism and angiotensin-converting enzyme inhibition are synergistic via an Endothelin B receptor-mediated and nitric oxide-dependent mechanism","volume":"15","author":"Goddard","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib381","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4196\/kjpp.2015.19.2.125","article-title":"Effect of the combination of CI-988 and morphine on neuropathic pain after spinal cord injury in rats","volume":"19","author":"Kim","year":"2015","journal-title":"Korean J. Physiol. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib382","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0165-0173(02)00202-3","article-title":"Long-term potentiation in spinothalamic neurons","volume":"40","author":"Willis","year":"2002","journal-title":"Brain Res. Rev."},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib383","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.pain.2011.12.013","article-title":"Calcium\/calmodulin dependent kinase II contributes to persistent central neuropathic pain following spinal cord injury","volume":"153","author":"Crown","year":"2012","journal-title":"Pain"},{"issue":"9","key":"10.1016\/j.biopha.2021.111563_bib384","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.pain.2013.05.018","article-title":"Reactive oxygen species contribute to neuropathic pain and locomotor dysfunction via activation of CamKII in remote segments following spinal cord contusion injury in rats","volume":"154","author":"Gwak","year":"2013","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2007.12.004","article-title":"Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair","volume":"118","author":"Chen","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2021.111563_bib386","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/18763863010030400117","article-title":"Cathepsin S inhibition attenuates neuropathic pain and microglial response associated with spinal cord injury","volume":"3","author":"Clark","year":"2010","journal-title":"Open Pain J."},{"issue":"14","key":"10.1016\/j.biopha.2021.111563_bib387","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/glia.21042","article-title":"Cathepsin S release from primary cultured microglia is regulated by the P2X7 receptor","volume":"58","author":"Clark","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.biopha.2021.111563_bib388","article-title":"Cathepsin inhibitors for treating microglia-mediated neuron loss in the central nervous system","author":"Booth","year":"2012","journal-title":"Google Pat."},{"key":"10.1016\/j.biopha.2021.111563_bib389","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-3-319-50174-1_9","article-title":"Sigma-1 receptor antagonists: a new class of neuromodulatory analgesics","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"12","key":"10.1016\/j.biopha.2021.111563_bib390","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.tips.2010.08.007","article-title":"The sigma-1 receptor chaperone as an inter-organelle signaling modulator","volume":"31","author":"Su","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib391","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2174\/157015908787386113","article-title":"Pharmacology and therapeutic potential of sigma1 receptor ligands","volume":"6","author":"Cobos","year":"2008","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.biopha.2021.111563_bib392","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neuropharm.2016.08.027","article-title":"Astrocyte sigma-1 receptors modulate connexin 43 expression leading to the induction of below-level mechanical allodynia in spinal cord injured mice","volume":"111","author":"Choi","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2021.111563_bib393","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fphar.2019.00222","article-title":"Repeated sigma-1 receptor antagonist MR309 administration modulates central neuropathic pain development after spinal cord injury in mice","volume":"10","author":"Castany","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib394","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-22217-9","article-title":"Critical role of sigma-1 receptors in central neuropathic pain-related behaviours after mild spinal cord injury in mice","volume":"8","author":"Castany","year":"2018","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.biopha.2021.111563_bib395","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1111\/j.1476-5381.2012.01942.x","article-title":"Pharmacological properties of S1RA, a new sigma\u20101 receptor antagonist that inhibits neuropathic pain and activity\u2010induced spinal sensitization","volume":"166","author":"Romero","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111563_bib396","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fphar.2021.614949","article-title":"Negative impact of sigma-1 receptor agonist treatment on tissue integrity and motor function following spinal cord injury","volume":"12","author":"Lattard","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib397","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.freeradbiomed.2011.01.026","article-title":"Roles of reactive oxygen and nitrogen species in pain","volume":"51","author":"Salvemini","year":"2011","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib398","doi-asserted-by":"crossref","DOI":"10.3171\/FOC.2008.25.11.E5","article-title":"Duration of lipid peroxidation after acute spinal cord injury in rats and the effect of methylprednisolone","volume":"25","author":"Christie","year":"2008","journal-title":"Neurosurg. Focus"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib399","first-page":"1","article-title":"Effect of oxidative stress induced by intracranial iron overload on central pain after spinal cord injury","volume":"12","author":"Meng","year":"2017","journal-title":"J. Orthop. Surg. Res."},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib400","doi-asserted-by":"crossref","DOI":"10.3171\/FOC.2008.25.11.E6","article-title":"Ultrastructure protection and attenuation of lipid peroxidation after blockade of presynaptic release of glutamate by lamotrigine in experimental spinal cord injury","volume":"25","author":"Tufan","year":"2008","journal-title":"Neurosurg. Focus"},{"issue":"6","key":"10.1016\/j.biopha.2021.111563_bib401","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1089\/neu.2013.3146","article-title":"Valproic acid protects motor neuron death by inhibiting oxidative stress and endoplasmic reticulum stress-mediated cytochrome C release after spinal cord injury","volume":"31","author":"Lee","year":"2014","journal-title":"J. Neurotrauma"},{"issue":"15","key":"10.1016\/j.biopha.2021.111563_bib402","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/BRS.0b013e3182895587","article-title":"Minocycline treatment inhibits lipid peroxidation, preserves spinal cord ultrastructure, and improves functional outcome after traumatic spinal cord injury in the rat","volume":"38","author":"Sonmez","year":"2013","journal-title":"Spine"},{"key":"10.1016\/j.biopha.2021.111563_bib403","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/586270","article-title":"Role of melatonin in traumatic brain injury and spinal cord injury","volume":"2014","author":"Naseem","year":"2014","journal-title":"Sci. World J."},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib404","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/jnc.12830","article-title":"Reactive oxygen species and lipid peroxidation inhibitors reduce mechanical sensitivity in a chronic neuropathic pain model of spinal cord injury in rats","volume":"131","author":"Hassler","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2021.111563_bib405","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s12017-019-08585-z","article-title":"Harpagophytum procumbens extract ameliorates allodynia and modulates oxidative and antioxidant stress pathways in a rat model of spinal cord injury","volume":"22","author":"Ungerer","year":"2020","journal-title":"Neuromol. Med."},{"issue":"12","key":"10.1016\/j.biopha.2021.111563_bib406","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1139\/cjpp-2016-0528","article-title":"Geraniol promotes functional recovery and attenuates neuropathic pain in rats with spinal cord injury","volume":"95","author":"Lv","year":"2017","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111563_bib407","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00210-020-01995-y","article-title":"The antioxidant N-(2-mercaptopropionyl)-glycine (tiopronin) attenuates expression of neuropathic allodynia and hyperalgesia","volume":"394","author":"Shahid","year":"2020","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib408","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1576","article-title":"Simultaneous intrathecal injection of muscimol and endomorphin\u20101 alleviates neuropathic pain in rat model of spinal cord injury","volume":"10","author":"Hosseini","year":"2020","journal-title":"Brain Behav."},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib409","first-page":"120","article-title":"Natural polyphenols and spinal cord injury","volume":"18","author":"Khalatbary","year":"2014","journal-title":"Iran. Biomed. J."},{"key":"10.1016\/j.biopha.2021.111563_bib410","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neuropharm.2013.09.013","article-title":"(\u2212)-Epigallocatechin-3-gallate (EGCG) modulates neurological function when intravenously infused in acute and, chronically injured spinal cord of adult rats","volume":"77","author":"Renno","year":"2014","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib411","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jnutbio.2005.10.005","article-title":"Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration","volume":"17","author":"Sutherland","year":"2006","journal-title":"J. Nutr. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib412","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/ijms17010049","article-title":"The anti-inflammatory compound curcumin enhances locomotor and sensory recovery after spinal cord injury in rats by immunomodulation","volume":"17","author":"Machova Urdzikova","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib413","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jss.2009.07.001","article-title":"Curcumin provides neuroprotection after spinal cord injury","volume":"166","author":"Lin","year":"2011","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.biopha.2021.111563_bib414","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/10790268.2019.1616147","article-title":"Curcumin promotes functional recovery and inhibits neuronal apoptosis after spinal cord injury through the modulation of autophagy","volume":"44","author":"Li","year":"2019","journal-title":"J. Spinal Cord Med."},{"key":"10.1016\/j.biopha.2021.111563_bib415","series-title":"Current and Combinative Curcumin Therapeutics for Treating Spinal Cord Injury, Curcumin for Neurological and Psychiatric Disorders","first-page":"419","author":"Indermun","year":"2019"},{"issue":"12","key":"10.1016\/j.biopha.2021.111563_bib416","first-page":"882","article-title":"Effects of resveratrol on Ca2+, Mg (2+)-ATPase activities after spinal cord trauma in rats","volume":"25","author":"Yang","year":"2002","journal-title":"Zhong Yao Cai: J. Chin. Med. Mater."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib417","first-page":"2237","article-title":"Resveratrol improves neurological outcome and neuroinflammation following spinal cord injury through enhancing autophagy involving the AMPK\/mTOR pathway","volume":"18","author":"Meng","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib418","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.sjbs.2016.10.019","article-title":"Resveratrol, an antioxidant, protects spinal cord injury in rats by suppressing MAPK pathway","volume":"25","author":"Fu","year":"2018","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.biopha.2021.111563_bib419","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.phymed.2018.01.001","article-title":"Rosmarinic acid attenuates development and existing pain in a rat model of neuropathic pain: an evidence of anti-oxidative and anti-inflammatory effects","volume":"40","author":"Rahbardar","year":"2018","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib420","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3344\/kjp.2021.34.1.35","article-title":"Antinociceptive effects of oleuropein in experimental models of neuropathic pain in male rats","volume":"34","author":"Chen","year":"2021","journal-title":"Korean J. Pain"},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib421","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4103\/ijabmr.IJABMR_58_19","article-title":"Effect of chrysin on mechanical hyperalgesia in chronic constriction injury-induced neuropathic pain in rat model","volume":"10","author":"Rayiti","year":"2020","journal-title":"Int. J. Appl. Basic Med. Res."},{"issue":"7","key":"10.1016\/j.biopha.2021.111563_bib422","doi-asserted-by":"crossref","first-page":"12270","DOI":"10.3390\/ijms150712270","article-title":"Chrysin suppressed inflammatory responses and the inducible nitric oxide synthase pathway after spinal cord injury in rats","volume":"15","author":"Jiang","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.111563_bib423","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ejphar.2015.11.023","article-title":"Involvement of AMPK\/SIRT1 pathway in anti-allodynic effect of troxerutin in CCI-induced neuropathic pain","volume":"769","author":"Gui","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib424","doi-asserted-by":"crossref","first-page":"7554","DOI":"10.3892\/mmr.2015.4357","article-title":"Effect of rutin on spinal cord injury through inhibition of the expression of MIP-2 and activation of MMP-9, and downregulation of Akt phosphorylation","volume":"12","author":"Zhang","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib425","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3892\/br.2014.267","article-title":"Analgesic effects of naringenin in rats with spinal nerve ligation\u2011induced neuropathic pain","volume":"2","author":"Hu","year":"2014","journal-title":"Biomed. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib426","first-page":"659","article-title":"Eugenol promotes functional recovery and alleviates inflammation, oxidative stress, and neural apoptosis in a rat model of spinal cord injury","volume":"36","author":"Ma","year":"2018","journal-title":"Restor. Neurol. Neurosci."},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib427","doi-asserted-by":"crossref","first-page":"41","DOI":"10.21010\/ajtcam.v14i5.6","article-title":"Neuroprotective effect corilagin in spinal cord injury rat model by inhibiting nuclear factor-kB, inflammation and apoptosis","volume":"14","author":"Zhang","year":"2017","journal-title":"Afr. J. Tradit. Complement. Altern. Med."},{"issue":"12","key":"10.1016\/j.biopha.2021.111563_bib428","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/sc.2009.55","article-title":"Levetiracetam in spinal cord injury pain: a randomized controlled trial","volume":"47","author":"Finnerup","year":"2009","journal-title":"Spinal Cord"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib429","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/sc.1991.4","article-title":"Diagnostic spinal anaesthesia in chronic spinal cord injury pain","volume":"29","author":"Loubser","year":"1991","journal-title":"Spinal Cord"},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib430","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.54.3.564","article-title":"Intravenous lidocaine in central pain A double-blind, placebo-controlled, psychophysical study","volume":"54","author":"Attal","year":"2000","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib431","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/00000542-200505000-00023","article-title":"Intravenous lidocaine relieves spinal cord injury paina randomized controlled trial","volume":"102","author":"Finnerup","year":"2005","journal-title":"Anesthesiol.: J. Am. Soc. Anesthesiol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib432","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/00002060-199603000-00002","article-title":"Effect of mexiletine on spinal cord injury dysesthetic pain1","volume":"75","author":"Chiou-Tan","year":"1996","journal-title":"Am. J. Phys. Med. Rehabil."},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib433","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000048402","article-title":"Continuous intrathecal clonidine administration for the treatment of neuropathic pain","volume":"75","author":"Uhle","year":"2000","journal-title":"Stereotact. Funct. Neurosurg."},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib434","first-page":"151","article-title":"The effect of intrathecal administration of muscimol on modulation of neuropathic pain symptoms resulting from spinal cord injury; an experimental study","volume":"2","author":"Hosseini","year":"2014","journal-title":"Emergency"},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib435","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096396","article-title":"Fatty acid amide hydrolase (FAAH) inhibitors exert pharmacological effects, but lack antinociceptive efficacy in rats with neuropathic spinal cord injury pain","volume":"9","author":"Hama","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib436","first-page":"506","article-title":"Nanovector\u2010mediated drug delivery for spinal cord injury treatment","volume":"6","author":"Caron","year":"2014","journal-title":"Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol."},{"issue":"11","key":"10.1016\/j.biopha.2021.111563_bib437","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood\u2013brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.biopha.2021.111563_bib438","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.2217\/nnm-2019-0355","article-title":"How can nanovectors be used to treat spinal cord injury?","volume":"14","author":"Rossi","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2021.111563_bib439","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3389\/fphar.2017.00245","article-title":"Biomaterials for local, controlled drug delivery to the injured spinal cord","volume":"8","author":"Ziemba","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"14","key":"10.1016\/j.biopha.2021.111563_bib440","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1039\/C6CS00636A","article-title":"Cellular uptake of nanoparticles: journey inside the cell","volume":"46","author":"Behzadi","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biopha.2021.111563_bib441","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2013.11.001","article-title":"Polymeric nanoparticle system to target activated microglia\/macrophages in spinal cord injury","volume":"174","author":"Papa","year":"2014","journal-title":"J. Control Release"},{"issue":"8","key":"10.1016\/j.biopha.2021.111563_bib442","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1046\/j.1460-9568.2002.01967.x","article-title":"Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat","volume":"15","author":"Calvo","year":"2002","journal-title":"Eur. J. Neurosci."},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib443","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/smll.201201888","article-title":"Microglia response and in vivo therapeutic potential of methylprednisolone\u2010loaded dendrimer nanoparticles in spinal cord injury","volume":"9","author":"Cerqueira","year":"2013","journal-title":"Small"},{"issue":"6","key":"10.1016\/j.biopha.2021.111563_bib444","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3109\/10611860903434001","article-title":"Novel multifunctional polyethylene glycol-transactivating-transduction protein-modified liposomes cross the blood-spinal cord barrier after spinal cord injury","volume":"18","author":"Liu","year":"2010","journal-title":"J. Drug Target."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib445","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.expneurol.2004.02.007","article-title":"In vivo magnetic resonance tracking of olfactory ensheathing glia grafted into the rat spinal cord","volume":"187","author":"Lee","year":"2004","journal-title":"Exp. Neurol."},{"issue":"13","key":"10.1016\/j.biopha.2021.111563_bib446","doi-asserted-by":"crossref","first-page":"R167","DOI":"10.1088\/0022-3727\/36\/13\/201","article-title":"Applications of magnetic nanoparticles in biomedicine","volume":"36","author":"Pankhurst","year":"2003","journal-title":"J. Phys. D: Appl. Phys."},{"issue":"11","key":"10.1016\/j.biopha.2021.111563_bib447","doi-asserted-by":"crossref","first-page":"9881","DOI":"10.1021\/nn4036014","article-title":"Selective nanovector mediated treatment of activated proinflammatory microglia\/macrophages in spinal cord injury","volume":"7","author":"Papa","year":"2013","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.biopha.2021.111563_bib448","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1089\/neu.2010.1409","article-title":"Single-walled carbon nanotubes chemically functionalized with polyethylene glycol promote tissue repair in a rat model of spinal cord injury","volume":"28","author":"Roman","year":"2011","journal-title":"J. Neurotrauma"},{"issue":"7","key":"10.1016\/j.biopha.2021.111563_bib449","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/jnr.22309","article-title":"Functional silica nanoparticle\u2010mediated neuronal membrane sealing following traumatic spinal cord injury","volume":"88","author":"Cho","year":"2010","journal-title":"J. Neurosci. Res."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib450","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jconrel.2013.03.009","article-title":"Mesoporous silica-supported lipid bilayers (protocells) for DNA cargo delivery to the spinal cord","volume":"168","author":"Dengler","year":"2013","journal-title":"J. Control Release"},{"issue":"1\u20132","key":"10.1016\/j.biopha.2021.111563_bib451","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000446647","article-title":"Nanoparticle technologies in the spinal cord","volume":"202","author":"Zuidema","year":"2016","journal-title":"Cells Tissues Organs"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib452","first-page":"49","article-title":"Polymeric nanoparticles-targeted drug delivery systems for treatment of CNS disorders and their possible endocrine disrupting activities","volume":"45","author":"Rollerova","year":"2011","journal-title":"Endocr. Regul."},{"key":"10.1016\/j.biopha.2021.111563_bib453","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2013.08.008","article-title":"Drug delivery to the central nervous system by polymeric nanoparticles: what do we know?","volume":"71","author":"Kreuter","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib454","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1039\/C4BM00311J","article-title":"Sustained delivery of bioactive neurotrophin-3 to the injured spinal cord","volume":"3","author":"Donaghue","year":"2015","journal-title":"Biomater. Sci."},{"issue":"13","key":"10.1016\/j.biopha.2021.111563_bib455","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1016\/j.biomaterials.2008.12.077","article-title":"Nanoparticle-mediated local delivery of Methylprednisolone after spinal cord injury","volume":"30","author":"Kim","year":"2009","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib456","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11095-007-9484-0","article-title":"Bioavailability effect of methylprednisolone by polymeric micelles","volume":"25","author":"Chen","year":"2008","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib457","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s11064-013-0991-6","article-title":"Spinal cord injury: a review of current therapy, future treatments, and basic science frontiers","volume":"38","author":"Varma","year":"2013","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.biopha.2021.111563_bib458","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biomaterials.2015.10.015","article-title":"Early modulation of pro-inflammatory microglia by minocycline loaded nanoparticles confers long lasting protection after spinal cord injury","volume":"75","author":"Papa","year":"2016","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib459","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/cn400182z","article-title":"Dendrimer advances for the central nervous system delivery of therapeutics","volume":"5","author":"Xu","year":"2014","journal-title":"ACS Chem. Neurosci."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib460","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.biomaterials.2010.09.002","article-title":"PEGylated Poly (amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors","volume":"32","author":"He","year":"2011","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.biopha.2021.111563_bib461","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1517\/17425247.2012.717928","article-title":"Lipid nanoparticles for cancer therapy: state of the art and future prospects","volume":"9","author":"Lasa-Saracibar","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib462","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1754-1611-6-18","article-title":"Affinity for, and localization of, PEG-functionalized silica nanoparticles to sites of damage in an ex vivo spinal cord injury model","volume":"6","author":"Chen","year":"2012","journal-title":"J. Biol. Eng."},{"issue":"6","key":"10.1016\/j.biopha.2021.111563_bib463","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/bab.1109","article-title":"Effects of magnetic nanoparticle\u2010incorporated human bone marrow\u2013derived mesenchymal stem cells exposed to pulsed electromagnetic fields on injured rat spinal cord","volume":"60","author":"Cho","year":"2013","journal-title":"Biotechnol. Appl. Biochem."},{"issue":"6","key":"10.1016\/j.biopha.2021.111563_bib464","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/mt.2015.50","article-title":"Intraspinal delivery of polyethylene glycol-coated gold nanoparticles promotes functional recovery after spinal cord injury","volume":"23","author":"Papastefanaki","year":"2015","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib465","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1754-1611-7-15","article-title":"Pushing the science forward: chitosan nanoparticles and functional repair of CNS tissue after spinal cord injury","volume":"7","author":"Chen","year":"2013","journal-title":"J. Biol. Eng."},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib466","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jconrel.2011.12.025","article-title":"Multiple drug delivery hydrogel system for spinal cord injury repair strategies","volume":"159","author":"Perale","year":"2012","journal-title":"J. Control Release"},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib467","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1517\/17425247.2013.751372","article-title":"Current options for drug delivery to the spinal cord","volume":"10","author":"Rossi","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"issue":"7","key":"10.1016\/j.biopha.2021.111563_bib468","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1021\/cn200030w","article-title":"Hydrogels in spinal cord injury repair strategies","volume":"2","author":"Perale","year":"2011","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib469","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016135","article-title":"Sustained delivery of activated Rho GTPases and BDNF promotes axon growth in CSPG-rich regions following spinal cord injury","volume":"6","author":"Jain","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2021.111563_bib470","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000339589","article-title":"Localized and sustained delivery of fibroblast growth factor-2 from a nanoparticle-hydrogel composite for treatment of spinal cord injury","volume":"197","author":"Kang","year":"2013","journal-title":"Cells Tissues Organs"},{"issue":"7","key":"10.1016\/j.biopha.2021.111563_bib471","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/sj.bmt.1705757","article-title":"Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury","volume":"40","author":"Parr","year":"2007","journal-title":"Bone Marrow Transpl."},{"issue":"10","key":"10.1016\/j.biopha.2021.111563_bib472","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1089\/scd.2009.0378","article-title":"HPMA-RGD hydrogels seeded with mesenchymal stem cells improve functional outcome in chronic spinal cord injury","volume":"19","author":"Hej\u010dl","year":"2010","journal-title":"Stem Cells Dev."},{"issue":"12","key":"10.1016\/j.biopha.2021.111563_bib473","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.biomaterials.2008.01.002","article-title":"Spatial distribution and acute anti-inflammatory effects of methylprednisolone after sustained local delivery to the contused spinal cord","volume":"29","author":"Chvatal","year":"2008","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.biopha.2021.111563_bib474","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.1007\/s12035-019-1468-7","article-title":"Nanocarrier-mediated Delivery of CORM-2 Enhances Anti-allodynic and Anti-hyperalgesic Effects of CORM-2","volume":"56","author":"Joshi","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2021.111563_bib475","first-page":"2259","article-title":"Iron oxide nanoparticles and magnetic field exposure promote functional recovery by attenuating free radical-induced damage in rats with spinal cord transection","volume":"8","author":"Pal","year":"2013","journal-title":"Int. J. Nanomed."},{"issue":"11","key":"10.1016\/j.biopha.2021.111563_bib476","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.4103\/1673-5374.282260","article-title":"Muscovite nanoparticles mitigate neuropathic pain by modulating the inflammatory response and neuroglial activation in the spinal cord","volume":"15","author":"Oh","year":"2020","journal-title":"Neural Regen. Res."},{"issue":"4","key":"10.1016\/j.biopha.2021.111563_bib477","doi-asserted-by":"crossref","DOI":"10.1088\/1741-2560\/8\/4\/046026","article-title":"Controlled release of 6-aminonicotinamide from aligned, electrospun fibers alters astrocyte metabolism and dorsal root ganglia neurite outgrowth","volume":"8","author":"Schaub","year":"2011","journal-title":"J. Neural Eng."},{"issue":"3","key":"10.1016\/j.biopha.2021.111563_bib478","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.jconrel.2012.05.034","article-title":"Drug-eluting microfibrous patches for the local delivery of rolipram in spinal cord repair","volume":"161","author":"Downing","year":"2012","journal-title":"J. Control Release"},{"issue":"6","key":"10.1016\/j.biopha.2021.111563_bib479","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.stemcr.2018.10.017","article-title":"Human oligodendrogenic neural progenitor cells delivered with chondroitinase ABC facilitate functional repair of chronic spinal cord injury","volume":"11","author":"Nori","year":"2018","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.biopha.2021.111563_bib480","doi-asserted-by":"crossref","DOI":"10.1177\/1744806917697006","article-title":"Polyamidoamine dendrimer-conjugated triamcinolone acetonide attenuates nerve injury-induced spinal cord microglia activation and mechanical allodynia","volume":"13","author":"Kim","year":"2017","journal-title":"Mol. Pain"},{"issue":"2","key":"10.1016\/j.biopha.2021.111563_bib481","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1208\/s12249-014-0235-3","article-title":"Protein-functionalized PLGA nanoparticles of lamotrigine for neuropathic pain management","volume":"16","author":"Lalani","year":"2015","journal-title":"AAPS PharmSciTech"},{"issue":"10","key":"10.1016\/j.biopha.2021.111563_bib482","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.3390\/ijms21103469","article-title":"CX3CR1-targeted PLGA nanoparticles reduce microglia activation and pain behavior in rats with spinal nerve ligation","volume":"21","author":"Noh","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.biopha.2021.111563_bib483","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1016\/j.nano.2017.07.010","article-title":"Single oral dose of cannabinoid derivate loaded PLGA nanocarriers relieves neuropathic pain for eleven days","volume":"13","author":"Berrocoso","year":"2017","journal-title":"Nanomed.: Nanotechnol. Biol. Med."},{"issue":"8","key":"10.1016\/j.biopha.2021.111563_bib484","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1021\/acsabm.9b00380","article-title":"Covalent poly (lactic acid) nanoparticles for the sustained delivery of naloxone","volume":"2","author":"Kassick","year":"2019","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.biopha.2021.111563_bib485","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jtemb.2017.11.002","article-title":"Enhanced pharmacological actions of p, p\u2019-methoxyl-diphenyl diselenide-loaded polymeric nanocapsules in a mouse model of neuropathic pain: behavioral and molecular insights","volume":"46","author":"Sari","year":"2018","journal-title":"J. Trace Elem. Med. Biol."},{"issue":"12","key":"10.1016\/j.biopha.2021.111563_bib486","doi-asserted-by":"crossref","first-page":"14283","DOI":"10.1021\/acsnano.9b07598","article-title":"A MnO2 nanoparticle-dotted hydrogel promotes spinal cord repair via regulating reactive oxygen species microenvironment and synergizing with mesenchymal stem cells","volume":"13","author":"Li","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2021.111563_bib487","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2147\/DDDT.S15817","article-title":"When is high-dose intravenous iron repletion needed? Assessing new treatment options","volume":"5","author":"Gozzard","year":"2011","journal-title":"Drug Des. Dev. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2021.111563_bib488","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/03007995.2019.1565709","article-title":"Lidocaine medicated plaster, an additional potential treatment option for localized post-surgical neuropathic pain: efficacy and safety results of a randomized, placebo-controlled trial","volume":"35","author":"Palladini","year":"2019","journal-title":"Curr. Med. Res. Opin."},{"issue":"6","key":"10.1016\/j.biopha.2021.111563_bib489","doi-asserted-by":"crossref","first-page":"874","DOI":"10.2174\/1871530319666190212170140","article-title":"The neuromodulatory effects of \u03c9-3 fatty acids and nano-curcumin on the COX-2\/iNOS network in migraines: a clinical trial study from gene expression to clinical symptoms","volume":"19","author":"Abdolahi","year":"2019","journal-title":"Endocr Metab. Immune Disord. -Drug Targets"},{"key":"10.1016\/j.biopha.2021.111563_bib490","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jneuroim.2019.01.007","article-title":"Nanocurcumin improves regulatory T-cell frequency and function in patients with multiple sclerosis","volume":"327","author":"Dolati","year":"2019","journal-title":"J. Neuroimmunol."},{"issue":"6","key":"10.1016\/j.biopha.2021.111563_bib491","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1177\/0963689718766279","article-title":"Significant improvement of acute complete spinal cord injury patients diagnosed by a combined criteria implanted with neuroregen scaffolds and mesenchymal stem cells","volume":"27","author":"Xiao","year":"2018","journal-title":"Cell Transpl."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221003486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221003486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:23:58Z","timestamp":1760099038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221003486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":491,"alternative-id":["S0753332221003486"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111563","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"On the therapeutic targets and pharmacological treatments for pain relief following spinal cord injury: A mechanistic review","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111563","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111563"}}